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ABSTRACT 
 
Congenital anomalies (CAs) are the leading cause of infant mortality and one of the 
leading causes of death for young children in developed countries.  As significant 
improvements have been seen world-wide in controlling childhood infectious disease 
and issues related to poor nutrition, CAs are now making a proportionally bigger impact 
on the health of the world’s children.  In addition to the impact of CA status on the 
individual child and one’s family, prevalence of CAs has a significant impact on the 
population, as children with birth defects can cost the system a great deal of money in 
the provision of specialized health and education services. 
When conducting surveillance of five selected CAs between 1990 and 1999, 
Saskatchewan Health found significant regional differences in the prevalence of these 
CAs.  The purpose of this study is to ascertain whether or not there is a regional 
difference in all types of CAs, to assess whether or not any regional disparities also exist 
in the use of health care services by children with and without CAs and to determine 
what factors influence children’s use of health care services in the study population. 
This study follows a birth cohort of 17,414 children (9169 cases and 8245 
controls) born between January 1, 1994 to December 31, 1998 until their 5th birthday, 
death or emigration out of Saskatchewan.  Through graphical analysis, it was revealed 
that while an overall regional difference does not exist in the prevalence of CAs in 
Saskatchewan, there are regional differences in the prevalence of 13 of the 22 specific 
categories of conditions studied.  One-way ANOVAs showed that children with CAs 
have higher numbers of physician visits (p<0.001) and hospitalizations (p<0.001), and 
longer lengths of stay in hospital (p<0.001) than children without CAs.  Regional 
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differences were found for all outcome variables for the total population, and for 
children with and without CAs.  The outcome with the most substantial differences 
between children with and without CAs was length of stay, which may indicate 
differential access to outpatient services throughout the province.  Finally, using 
Anderson’s theoretical framework of factors that influence the use of health care 
services (need characteristics, predisposing characteristics and enabling characteristics) 
three negative binomial models were built to examine children’s use of health care 
services using variables from each category.   
This study found significant regional differences for all outcome measures 
studied, and found that region of residence was a significant predictor of children’s use 
of health care services even after accounting for a variety of other maternal and child 
factors. 
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CHAPTER ONE: INTRODUCTION 
 
Congenital anomalies (CAs) are any abnormalities that are present at birth, even if they 
are not detected until much later (1, 2).  In developed nations, CAs are the leading cause 
of infant mortality, and one of the leading causes of death for young children (3, 4).  
While the risk of dying as a result of a CA (or multiple CAs) has decreased between 
1950 and 2000, the rate of decline has slowed in recent years; infant mortality (deaths to 
live born children in the first year of life), however, remains a significant issue in our 
society today (3, 5).  As significant improvements have been seen world-wide in 
controlling childhood infectious diseases and issues related to poor nutrition, CAs now 
have a proportionally bigger impact on the health of the world’s children (6, 7).  In 
addition to the impact of CA status on the individual child and family, prevalence of 
CAs has a significant impact on the population, as children with birth defects can cost 
the system a great deal of money in the provision of specialized health and education 
services (7).  CA status is likely to be a major predictor of children’s use of health care 
services as these children may need to use a higher level of services to treat and/or 
manage their birth defect and they may be more susceptible to other comorbidities due 
to the presence of a CA than unaffected children.  
1.1 Study Rationale 
In 2000, Saskatchewan Health released a report entitled ‘The Epidemiology of Infant 
Mortality in Saskatchewan 1982-1996’.  To date this is the only study of its kind in 
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Saskatchewan.  This report showed that while the absolute number of infant deaths due 
to congenital anomalies decreased by 33% from 246 in the first five year period (1982-
1986) that the study considered to 165 in the second five year period (1992-1996), the 
proportion of deaths due to CAs remained stable at approximately 28% throughout the 
entire study (5).  This indicates that the importance of CA status as it relates to infant 
mortality has not lessened over time.  A nation-wide study found similar results (8).  In 
Canada, the rate of infant mortality due to lethal congenital anomalies decreased from 
3.11 per 1000 live births in 1981 to 1.89 per 1000 live births in 1995, this represents 
30% and 34% of infant mortality respectively (8).  This same study examined provincial 
differences in the rates of infant mortality due to lethal CAs and found that the province 
of Saskatchewan had a significantly higher overall rate of infant deaths due to CAs than 
the province of Quebec which served as the reference group (2.48 deaths per 1000 live 
births versus 1.91 deaths per 1000 live births) (8).   
These findings, along with more current unpublished data collected by the 
Population Health Branch at Saskatchewan Health, shows that both rates of infant 
mortality and CAs are not consistent across all health regions (5, 9).  Figure 1.1 shows 
regional differences for the combined prevalence of several selected CAs: neural tube 
defects (NTDs), limb reduction deficits, Down syndrome, cleft lip/cleft palate and 
congenital heart defects.  The prevalence of these conditions ranges from a low of 54 per 
1000 live births in the Cypress Health Region to a high of 163 per 1000 live births in 
Northern Saskatchewan (this includes the Keewatin Yatthé Health Authority, the 
Mamawetan Churchill River Health Authority, and the Athabasca Health Authority). 
2 
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Figure 1.1: Combined prevalence of five selected CAs (neural tube defects, 
limb reduction deficits, Down syndrome, cleft lip/cleft palate and congenital 
heart defects) by regional health authority (1990-1999) (9) 
 
While it is known that there is a regional disparity in the rates and types of CAs, 
it is not known whether this same disparity extends to the health outcomes of children 
born with CAs in their first five years of life.  By further analyzing the regional 
differences in CAs and the use of health care services by region for children with CAs as 
compared to those without CAs in the first five years of life, a better understanding of 
CAs and the subsequent health care burden in Saskatchewan can be achieved.  By 
examining regional differences with regards to various aspects of population 
demographics that have been shown to have an effect on healthy child development, the 
determinants of regional disparities will be revealed along with information on how to 
allocate resources to better manage the care of vulnerable children in Saskatchewan 
(10).  
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1.2 Objectives and Research Questions 
The purpose of this study is to determine whether or not any regional disparities exist in 
the use of health care services for children with and without CAs, and to understand 
what factors influence children’s use of health care services in the study population. 
This thesis will address three principal questions:  
• Question One: Is the level of health care used by children with CAs significantly 
different from the level of health care used by children without CAs?   
• Question Two: Is there a regional difference in the level of health care used by 
children in their first five years of life?  Does this relationship hold for children 
with and without CAs?  
• Question Three: What factors influence the level of health care utilization in the 
first five years of life for children in Saskatchewan? 
 It is hypothesized that children with CAs will utilize significantly more health care 
services than children without CAs in their first five years of life.  Furthermore, it is 
believed that this relationship will be significantly affected by a variety of factors related 
to one’s illness level (need), factors that make certain individuals more inclined to 
access health care services such as one’s values, socio-economic status and gender 
(predisposing characteristics) and factors that permit someone to access services such as 
the availability of nearby health services (enabling characteristics) (11).   
This type of research is important because if a regional difference is found in the 
use of health care services (especially for children with congenital anomalies, an already 
vulnerable population), it provides strong evidence to the regional health authorities and 
the provincial ministry of health that more needs to be done to “equalize” the differential 
health care utilization patterns across regions.  
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CHAPTER TWO: LITERATURE REVIEW 
 
This chapter provides an overview of the literature around the major themes of this 
study: congenital anomalies, health disparities and health care utilization.  While some 
studies exist that tie two of these three themes together, no studies could be found that 
link all three themes.  The chapter begins by describing congenital anomalies 
(definitions, causes, types and prevention), next is a discussion on health disparities and 
how geographical health disparities relate to healthy child development, and finally a 
discourse on the factors that contribute to one’s use of health care services.  These 
sections are followed by a discussion on the provision of health care services in 
Saskatchewan and finally the use, validity and reliability of administrative databases in 
health research.  
2.1 Congenital Anomalies 
2.1.1 What is a Congenital Anomaly? 
The term congenital anomaly (also known as [a.k.a.] birth defect, congenital 
malformation, congenital abnormality) encompasses any abnormality that is present at 
birth, even if it is not detected until much later (1, 2).  Various sources estimate the 
prevalence of CAs to be in the range of 1-3% of all live born infants (and considerably 
higher for infants that are stillborn or spontaneously aborted) (2, 12, 13).  This rate 
increases to 5-6% when the ascertainment period is extended to the age of five or six 
years (2, 12, 13).  CAs can be subdivided into major and minor anomalies related to 
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their clinical significance (1).  In addition to these types of CAs, there are normal 
variations of development that are seen in all individuals (1). 
 There are four clinically relevant types of CAs: malformations, disruptions, 
deformations and dysplasia (1).  A malformation is a “morphological defect of an organ, 
part of an organ, or larger region of the body that results from an intrinsically abnormal 
developmental process” (1).  A disruption is a “morphological defect of an organ, part of 
an organ, or larger region of the body that results from the extrinsic breakdown of, or an 
interference with, an originally normal developmental process” (1).  A deformation is 
“an abnormal form, shape or position of a part of the body that results from mechanical 
forces” (1).  Dysplasia is “an abnormal organization of cells into tissue(s) and its 
morphological result(s), … [it is] causally nonspecific and often affects several organs 
because of the nature of the underlying cellular disturbances” (1).   
Physical defects develop during the period of organ formation called 
organogenesis (weeks 3-11 of pregnancy), while most CAs that cause developmental 
delay occur later in pregnancy when the brain is maturing (1).  Figure 2.1 illustrates the 
sensitive stages of development for the various organ systems.   
6 
 
Figure 2.1: Sensitive stages of development (1) 
 
2.1.2 Causes of Congenital Anomalies 
As seen in Figure 2.2, the majority of CAs are of unknown origin, which makes 
prevention problematic.  Generally CAs, of known origin, are due to one of three 
principal causes: genetic factors, environmental factors, or a combination of genetic and 
environmental factors (multifactorial inheritance) (2). 
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Figure 2.2: Causes of congenital anomalies (2) 
 
 After the thalidomide tragedy in the 1950s, a great deal of emphasis was placed 
on the potentially harmful role that drugs can play in the development of CAs.  While 
Thalidomide is an extreme example of the potential teratogenicity of a pharmaceutical 
product, only 1% of CAs with a known cause are attributed to drug therapy (13).  
Furthermore, there are only approximately 25 drugs that are currently in use that are 
known to have a teratogenic effect (13).   
 In addition to pharmaceuticals, other environmental agents that have been shown 
to cause CAs include: maternal behaviours such as smoking, alcohol use, and poor 
nutritional status; infectious agents such as rubella, syphilis, and herpes simplex virus; 
high-dose ionizing radiation; and environmental contaminants such as herbicides, 
pesticides, and methyl mercury (14).  When examining the potential teratogenicity of an 
environmental agent, one must keep in mind that for an agent to act as a teratogen, the 
fetus must have been exposed to at least the threshold dose, during the sensitive period 
of development for which that particular substance is known to have an effect (see 
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Figure 2.1) (14).  Only a small percentage of CAs are caused by things in one’s 
environment.  The largest known cause of CAs is genetics (14).  Genetic causes of birth 
defects can be either autosomal or sex-linked in nature, recessive or dominant traits, 
single-gene or multiple-gene disorders, chromosomal defects, or be related to new 
mutations in the fetus (14).   
2.1.3 Types of Congenital Anomalies 
CAs – regardless of their cause – can affect any organ or system in the body, yet some 
types of CAs are more common then others (1).  Most CAs can be classified under the 
general categories of musculoskeletal defects, congenital heart defects, digestive system 
defects, circulatory system defects, central nervous system defects, urinary system 
defects and genital organ defects.  Figure 2.3 illustrates the prevalence of the most 
common groups of CAs in Canada in 1995 (15).  
Eye
Integument
Respiratory system
Ear, face, and neck
Down’s syndrome
Cleft lip/palate
Genital organ
Urinary system
Central nervous system
Circulatory system
Digestive system
Congenital heart defects
Musculoskeletal
Cases per 10,000 births
 
Figure 2.3: Prevalence of the most common types of CAs in Canada (*excluding Nova 
Scotia and Quebec) per 10,000 births (15)  
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A study conducted in Glasgow, UK examining the prevalence of selected CAs from 
1980 to 1997 found that during this time period in Glasgow, the prevalence of most CAs 
declined (6).  Overall, statistically significant decreases in prevalence were seen for CAs 
of the ear (88% decrease), CAs of the heart (69% decrease), CAs of the integument 
(67% decrease), CAs of the nervous system (61% decrease), CAs of limbs (54% 
decrease), and CAs of the urogenital system (including the renal system) (31% decrease) 
(6).  In this same time period, an increase was seen in chromosomal abnormalities (50% 
increase) (6).  Despite an overall decrease in the prevalence of CAs from 382 per 10,000 
births in 1980 to 238 per 10,000 births in 1997, the proportion of affected children 
remained stable around 2.5% (6). 
2.1.4 Prevention of Congenital Anomalies 
The prevention of birth defects is an important public health issue as birth defects tend 
to reoccur in families due to the shared genetic and environmental factors (16).  
Additionally, a longitudinal, population-based study conducted in Norway examining 
the survival of females with birth defects found that only 80% of those with birth defects 
survived until their 15th birthday compared to 98% of subjects without birth defects (i.e. 
children with CAs were more likely to die before their 15th birthday than children 
without CAs) (16).  This study went on to examine the likelihood of females with birth 
defects to have children by the age of 30 compared to their non-affected peers, and 
found that women with birth defects were one third less likely to give birth in this time 
period (16).  Additionally, the children of women who had a birth defect were more 
likely to have a birth defect themselves than the children of women without birth 
defects; however, this increased risk was only for the condition that affected the mother, 
 10
not birth defects in general (i.e. women with cleft palate had a higher risk of having a 
child with cleft palate, but not with a congenital heart defect) (16).  The increased 
relative risk of birth defects in the offspring of women with birth defects ranged from 
5.5 to 82 depending on the defect (16). 
When discussing the “prevention” of CAs, quite frequently prevention is used as 
a pseudonym for early termination.  While some large-scale prevention practices have 
been implemented (such as the fortification of foods with folic acid to prevent neural 
tube defects) and some educational programs have shown some degree of success in 
encouraging pregnant women to adapt healthier lifestyles, many CAs cannot be 
prevented.   
 Screening healthy women for disease and their unborn baby’s risk of disease has 
become part of the routine practice of prenatal care, as advances in medical diagnostic 
technology has allowed these tests to be administered more easily, safely and cheaper 
than ever before (17, 18).  This practice of routine screening (especially when women 
are considered “high-risk” due to having had a previous child with a congenital 
anomaly, is of advanced maternal age, or have certain pre-existing conditions) can have 
many benefits – it may help provide peace of mind and reduce stress to know that one’s 
child is unlikely to have a certain condition, or if it is revealed that the child has a CA, it 
provides time for families to decide how they would like to proceed (19).  That being 
said, no test is perfect, and false-positive results can be extremely distressing and 
sometimes can result in the termination of an unaffected fetus (19, 20).  Just as 
distressing, can be the psychological impact of a false-negative result when parents were 
advised that their child was not going to have a CA, only to find out once the child is 
 11
delivered that s/he has a potentially serious disability (20).  In addition to the 
psychological burden that can be associated with the routine screening for certain CAs 
in pregnancy, there is a minefield of ethical issues surrounding this practice that 
involves society’s acceptance of disabled persons, what kind of life is worth living and 
who is able to make that decision for others, and the “eugenic thrust in the practice of 
selectively aborting fetuses with disabilities” (18).  This is not to imply that a woman 
who chose to abort a fetus with a CA is practicing eugenics, merely that as a whole, 
society needs to be more accepting of individuals with disabilities. 
 While the actual impact of the routine testing for CAs in the antenatal period is 
unknown, it is suspected that there is a strong correlation between the decrease in the 
prevalence of specific CAs (such as anencephaly and spina bifida) and the increase in 
screening for specific CAs (21).  Many CA surveillance systems are not able to capture 
the true incidence of CAs as they tend to only record CAs for live born infants, 
stillbirths when the cause is known, or fetuses who are carried beyond a certain 
gestational age.  Therefore it is impossible to ascertain whether there has really been a 
decrease in rates of specific CAs in recent years or if there has simply been an increase 
in prenatal diagnosis of these CAs and a subsequent increase in early terminations of 
these pregnancies (21).  A Canadian study by researchers for the Fetal and Infant Health 
Study Group of the Canadian Perinatal Surveillance System found that between 1991 
and 1997 fetal deaths from pregnancy terminations increased by 578%, or almost 6-fold, 
with the most significant increase occurring in 1995 (22).  The researchers also found 
that while infant mortality rates due to congenital anomalies had remained stable from 
1991 to 1995, there was a 21% decrease between 1995 and 1996, and that infant 
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mortality rates due to CAs had remained low in 1997 (22).  During this same time 
period, both the rate of prenatal testing for CAs and the selective termination of affected 
pregnancies were increasing, both of which are related to the overall decrease in 
Canada’s infant mortality rate (22). 
2.2 Health Disparities 
2.2.1 What is a Health Disparity? 
A health disparity (a.k.a. inequality) is a difference between two or more population 
groups on the basis of a specific criterion related to one’s health status (23, 24).  Some 
definitions are more specific as they define a health disparity as a difference in health 
status that is unnecessary, avoidable, unfair and unjust (known as health inequities as 
opposed to inequalities) (23).  Many disparities are caused by inequities. 
 Disparities have been noted for various population groups for all of Health 
Canada’s determinants of health (income and social status, physical environments, 
social environments, personal health practices and coping skills, social support 
networks, biology and genetic endowment, culture, gender, health services, healthy 
child development, education, employment and working conditions) (23, 25).  This 
project will examine only two of these determinants – healthy child development and 
health services.   
2.2.2 Geographic Health Disparities and Healthy Child Development 
Healthy child development has one of the most far-reaching effects of all the health 
determinants, as it affects the way a child’s brain develops, which in turn reflects his/her 
success in school (which will have an impact on the amount of education a child 
receives, the type of job s/he gets, how much money an individual will make and what 
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sort of physical environment one will live in) (23).  Furthermore, healthy child 
development helps children develop their social skills, which in turn impacts their 
coping abilities later in life and their personal health practices.    
While several studies have shown a disparity in children’s health across 
communities with regard to socioeconomic status (SES), the availability of health 
services, and various other demographic factors, no published work appears to exist that 
can explain why there is such a regional disparity with regard to CA rates in 
Saskatchewan or what impact this disparity has on the overall health of these children 
(10). 
While individual factors are known to have an impact on health, the social 
environment in which one lives also has an effect over and above individual 
characteristics (26).  While in Canada it is known that health outcomes differ at the 
regional level, it is still unknown to what extent this regional disparity is due to the 
composition of the population in each area and the social context in a region (26).  
Generally it is believed that individuals who live in the same health region tend to be 
more alike than individuals living in a different health region as they share similar 
experiences related to things such as the environment, health care services, culture and 
health behaviour (26).  These conclusions are questionable in large regions with diverse 
populations that encompass both inner-city and rural areas as is seen in Saskatchewan; 
however, may be accurate for more homogeneous areas.  Tremblay and Berthelot 
concluded that regional differences with regard to the availability of health care services 
are not a factor in the disparities of individual health status that exist between regions 
(26). 
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It has been shown that individuals who live in neighbourhoods with low SES 
during their pregnancy are more likely to have an adverse birth event (i.e. having a child 
with a CA or having a low birth weight baby) than individuals who live in a 
neighbourhood with a higher level of SES (10).  Researchers found that low SES 
residents who lived in low-SES neighbourhoods and low SES residents who did not live 
in low-SES neighbourhoods both had an increased risk of having a child with a neural 
tube defect (27).   
A study conducted in Ireland in the early 1990s determined that children living 
in poor areas were approximately nine times more likely to be hospitalized for any 
reason than children who did not live in poor areas (28).  A more recent Canadian study 
indicated that in their first year of life, children in low SES families use more treatment 
related health services and less preventative health services than children in higher SES 
families; and that parental education plays a bigger role in determining the use of health 
services than parental income (29). 
While this information on the impact of SES (measured by parental income and 
education level) on the risk of having a child with a CA and the child’s use of health 
care services is interesting, SES alone cannot explain the regional difference in CA 
rates; nor does it provide enough evidence to accurately predict whether or not children 
with CAs in a particular health region will use a significantly different amount of health 
services compared to children with CAs in another health region.  This study will be 
able to begin to answer these questions. 
In addition to health disparities as they relate to socioeconomic status, in 
Saskatchewan there is a need to examine disparities as they relate to access to health 
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services (most especially in remote communities in the northern part of the province) 
and the gross health disparities that exist between Aboriginals and non-Aboriginals (30).  
Studies have shown that health care is less accessible for rural residents than urban 
residents and that this problem is further magnified for remote communities (31). 
It is well known that Aboriginal people in Saskatchewan experience many health 
disadvantages.  Multiple studies have shown that people of Aboriginal ancestry in 
Canada, and elsewhere throughout the developed world, suffer from more health 
problems than the general population (32-35).  These health disparities are not limited to 
Aboriginal people living in urban environments but also those living on reserves or in 
isolated communities.  Geographic isolation has been shown to negatively impact health 
status as access to health professionals and services, in particular for prevention, and 
secondary treatment is often challenging for residents in remote or isolated locations 
(34, 36).  Finally, many Aboriginal people are living in poverty which further impacts 
their health status (33, 35). 
2.3 Health Services Utilization 
In 1968, the federal government approved the Medical Care (Medicare) Act, which 
granted medical insurance to all Canadian citizens free of charge by removing payments 
from the point of service (37).  Almost twenty years later, the Canada Health Act was 
passed to ensure that all of the Canadian provinces and territories upheld the principles 
of accessibility, comprehensiveness, portability, public administration and universality 
in order to continue receiving federal transfers for health care (38).  These two pieces of 
legislation act as the backbone on which the Canadian health care system today is based 
on.  They ensure that all Canadians, regardless of what province they live in, or if they 
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live in a rural area or an urban centre have access to medically necessary services 
without financial impediments (31, 39, 40). 
 Use of health care services is commonly believed to be a type of individual 
behaviour, with the volume of services used determined by the predisposition of an 
individual to use health services, the person’s ability to access services and how sick an 
individual is (11).  Figure 2.4 outlines Anderson and Newman’s model of the individual 
determinants of health services utilization.  Predisposing determinants are factors that 
are present before the illness begins and they explain in part why some people use 
services more than others; enabling determinants are characteristics that represent how 
people use health services; and need, or illness level, represents a person’s current health 
status (11, 41).  Poor health is the most immediate predictor for health care utilization 
(11, 41).   
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Figure 2.4: Individual determinants of health services utilization (11).   
 
A meta-analysis conducted by a nurse-researcher at the University of Alberta 
examined the barriers and facilitators in the health care relationship that either prevented 
or encouraged Canadians with chronic diseases to access health services (please see 
Table 2.1 for a summary of the findings) (39).  It is interesting to note that despite the 
broad inclusion criteria for this meta-analysis, and the twelve-year study period (1990-
2002), the researcher found that there is a significant lack of research on the 
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geographical barriers to access, especially in remote areas such as the Northwest 
Territories and Nunavut (39).   
Table 2.1: Barriers and facilitators to accessing health services (39) 
Barriers Facilitators 
Poor relationship with service provider as 
characterized by provider disbelief of 
family or client perceptions, 
undervaluing/devaluing of client or family 
knowledge, inappropriate use of power, 
provision of inadequate information to 
clients 
Open/trusting relationship between service 
provider and patient 
Previous negative experiences of clients 
with service providers and fear of privacy 
violations 
Personal follow-up contact by service 
provider (i.e. appointment reminders, etc) 
Gender or sexual identity differences 
between patients and service providers 
Same gender/sexual identity between 
service providers and clients 
Language or cultural differences between 
clients and service providers 
Service provider displays sensitivity and 
understanding of client culture; advice by 
service provider fits with the cultural 
beliefs of the client 
Differences in beliefs between 
marginalized groups and service providers, 
along with fear of discrimination, stigma 
or humiliation 
Client knowing someone who works in the 
system who can advocate on his/her behalf 
Differences in generational values Personal/social connection between patient 
and service provider 
Uncertainty or fear about the outcome of 
the encounter 
 
 
While Anderson and Newman’s model and information on barriers and 
facilitators to access are widely used to understand adult’s use of health care services, it 
is unknown how adaptable either of these models are to children, where typically 
predisposing characteristics of the parents, and things that inhibit or encourage parental 
access to care are more likely to influence the child’s use of health care services than the 
child’s predisposing characteristics.  There is a documented association between 
maternal use of selected health care services and children’s use of the same level of 
health care services for: any doctor visits, six or more doctor visits (in a one year 
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period), any emergency room visits, any hospitalizations, and any mental health visits 
(42).  Another study found that, in Sweden, geographic location (i.e. urban versus rural) 
did have an impact on adult’s use of health care services, although it did not impact 
children’s use of health care services in the first seven years of life (43).  This same 
study found a correlation between high-consulting children and sicker parents, 
indicating that disease is in large part a family matter and was not unique to one 
individual within the family (43).   
Even though it is not uncommon to see small-area variations in the use of health 
care services, one must be cautious when interpreting these differences (44).  
Differences in the use of health care services between areas could arise due to any 
number of ‘systems related’ factors such as the population’s need for services, the 
availability of health care services, people’s ability to pay (although this is not common 
in Canada where the individual patient does not pay directly at the point of service for 
most health care services), variations in local medical cultures, or clinical uncertainty 
(44).  One must also consider that the small-area variations may be seen merely due to 
chance, bias and/or unaccounted for confounding (44). 
 Despite the fact that financial barriers that prohibit access to medical care are 
believed to have been removed in Canada, one cannot forget other barriers to care 
brought about by low income.  A study in the United States found that the parents of 
low-income children as compared to the parents of middle-to-high income children were 
more likely to report having difficulty getting a referral to specialists (2.4% vs. 1.0%), 
and that their health care provider never or only sometimes listened carefully to them 
(10.0% vs. 5.1%), explained things clearly to them (9.6% vs. 3.4%), or showed respect 
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for what they had to say (9.2% vs. 4.2%) (45).  This same study found that middle-to-
high income children were less likely than low-income children to visit an emergency 
room (11.5% vs. 14.6%)  (45).  Additionally, low-income children were more likely to 
be admitted to the hospital for ambulatory case sensitive (ACS) conditions (conditions 
that are amenable to primary care intervention and if treated appropriately should not 
lead to subsequent secondary/tertiary care) (45, 46).  This is indicative of the middle-to-
high income children receiving more appropriate or timely care from primary health 
practitioners, which generally results in higher income children being able to avoid more 
costly tertiary (in hospital) care (45).  Similar findings have also been reported in 
Canada (41). 
 A study conducted in Nova Scotia examined the differences in the receipt of 
obstetric services by socio-economic status and found that affluent women were equally 
likely to have a cesarean section or labour induction than less affluent women (30).  
However, some important differences were noted; the researchers found that a larger 
proportion of pregnant women over 35 years of age came from more affluent 
households, and that this phenomenon was even more pronounced when it came to 
nulliparous women (30).  This finding has direct implications on this study as advanced 
maternal age is associated with a variety of CAs – most notably Down Syndrome (47).  
Other notable findings from the study by Joseph et al. include: women in a lower 
socioeconomic group were less likely to attend prenatal classes or be married, and were 
more likely to smoke, weigh 75kg or more, and live in rural areas (30).  These 
differences are important because they encompass a variety of lifestyle choices that can 
have negative impacts on child development.  Maternal smoking is a significant public 
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health concern as most women who smoke during their pregnancy will continue to 
smoke after giving birth, meaning that their children have not only been exposed to 
nicotine and other harmful chemicals in utero, but also to environmental tobacco smoke 
(ETS) in the home (48).  Both of these situations have been shown to negatively impact 
child development as maternal smoking has been linked to low birth weight (<2500g), 
very pre-term birth (<32 weeks gestation), perinatal death and lower rates of 
breastfeeding initiation and duration; furthermore, ETS has been shown to be associated 
with lower respiratory infections, Sudden Infant Death Syndrome (SIDS), middle ear 
disease and asthma in children (49, 50). 
 When examining the use of health care services in Canada it is important to 
acknowledge the difficulties faced by rural and remote communities.  Access to health 
professionals and services in rural areas, and even more so in the North, is a problem – 
physicians are often few and far between and typically do not stay in these communities 
on a permanent basis (36).  In addition to challenges caused by the lack of health 
professionals, harsh weather conditions in the winter often impedes travel to other 
communities and to health care facilities further south (36).   
There is also a need for culturally appropriate care to address the unique health 
care needs of Saskatchewan’s Aboriginal population.  First Nations’ health clinics exist 
on reserves to provide culturally appropriate, interdisciplinary care to those who live on 
the reserves (33, 51).  These same benefits are not available for Aboriginals who live in 
urban communities (33, 51).   
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2.4 Saskatchewan Context 
It has long been a source of pride for Saskatchewan residents that Saskatchewan has 
been an innovator in health care for the past fifty years (52, 53).  In 1947, Saskatchewan 
was the first Canadian province to provide universal hospital care insurance to its 
citizens, and again in 1962, Saskatchewan was the first province to provide 
comprehensive medical insurance to all of its citizens (52). 
 The years after World War II were marked by tremendous growth in the health 
care industry in Canada, but most particularly in Saskatchewan.  Thanks to increased 
federal funding transfers, provinces were able to construct new hospitals using 50¢ 
dollars, as every dollar that the provinces spent constructing hospitals was matched by 
the federal government (53).  In this era, the government of Saskatchewan decided that a 
series of small, rural hospitals was the best way to provide health care to its population 
as a large proportion of the population lived in rural communities, and travel between 
communities was difficult due to harsh winters and poor road conditions (53).  And 
while this decision made sense at the time, it didn’t take long before this delivery system 
for health services became obsolete (53).  As early as 1961, reports commissioned by 
the provincial government argued that Saskatchewan no longer required its small rural 
hospitals (53).  While eight (out of a recommended 38) hospitals were closed in 1967, 
and an additional three were closed in the early 1970s (53).  No more hospitals were 
closed until the 1990s due to fear of political retribution (53).  In fact, in the late 1980s 
and the early 1990s a great deal of money was spent building additional rural hospitals 
and renovating existing ones (53).  In 1992 there were 134 hospitals in Saskatchewan 
serving approximately one million people (52).  In comparison, Quebec, whose 
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population is approximately seven times the population of Saskatchewan, had far fewer 
hospitals (52). 
 In the 1980s and early 1990s two things were happening world-wide that would 
necessitate changes in the way health care was delivered in Saskatchewan (53).  There 
was an economic recession and a shift in thinking for academics and politicians was 
occurring as new research on the social determinants of health emerged (53).  In order to 
address both of these phenomena, the government of Saskatchewan decided that they 
would move towards a ‘Wellness’ model of care that would emphasize health promotion 
and disease prevention along with reducing family violence, stress, unemployment, drug 
abuse and poverty (53).  Focusing on prevention of disease instead of just treating 
disease involved the process of regionalization, whereby the 400 plus boards that 
represented hospitals, home care, long term care and ambulances were mandated by the 
provincial government to amalgamate by August 17, 1993 (53).  Municipalities were left 
to their own devices to determine how they wanted to consolidate, which resulted in the 
formation of 32 health districts and the Athabasca Health Authority (please see Figure 
2.5) (53).  To further complicate this situation, the provincial government also 
announced that as of October 1, 1993 they were converting 52 small rural hospitals into 
either Wellness Centres or long-term care facilities (53).   
 Citizens were extremely distressed and angry at the prospect of losing their small 
town hospitals; they felt that the provincial government was abandoning rural residents 
and they were concerned about how these ‘conversions’ would impact their health (52, 
53).  Interestingly, in a study conducted in 2001 that examined mortality rates in 
communities that had lost their hospital, still had their hospital and had never had a 
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hospital, researchers found that those who lived in a community that had never had a 
small hospital had the lowest mortality rates of all the groups (52).  Furthermore, they 
found that the communities in which the hospitals had been closed had lower mortality 
rates than in communities that kept their hospitals (52).  The researchers hypothesized 
that this surprising trend was because the presence of small hospitals unintentionally 
created patterns of care and dependencies that resulted in poorer outcomes (52). 
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Figure 2.5: Map of Saskatchewan health districts (54) 
  
It wasn’t long before the provincial government realized that the health districts 
were too small to provide the economies of scale that would be required to reduce costs 
or to offer the types of services that are required for a Wellness Model.  Consequently, 
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in 2002 the health districts were again amalgamated – this time into 13 Regional Health 
Authorities (RHAs) (please see Table 2.2 and Figure 2.6).   
Table 2.2: Amalgamation of health districts into regional health authorities  
Health Districts Regional Health Authorities 
Athabasca Health Authority Athabasca Health Authority 
Keewatin Yatthé Keewatin Yatthé 
Mamawetan Churchill River Mamawetan Churchill River 
Northwest, Lloydminster, Twin Rivers, 
Battlefords 
Prairie North 
Parkland, Prince Albert Prince Albert Parkland 
North-East, North Central, Pasquia Kelsey Trail 
Greenhead, Prairie West, Midwest Heartland 
Saskatoon, Gabriel Springs, Central Plains, 
Living Sky 
Saskatoon 
Assiniboine Valley, East Central, North 
Valley 
Sunrise 
Southwest, Swift Current, Rolling Hills Cypress 
South Country, Moose Jaw-Thunder Creek Five Hills 
Regina, Touchwood Qu’Appelle, 
Pipestone 
Regina Qu’Appelle 
South Central, South East, Moose 
Mountain 
Sun Country 
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Figure 2.6: Map of Saskatchewan regional health authorities (55) 
2.5 Utility, Validity and Reliability of Administrative Databases  
Administrative data (data collected for some administrative purpose, not primarily for 
research or surveillance) and health care claims data (hospital and physician billings) are 
commonly used to assess the population impacts of health issues (44, 56, 57).  By 
linking the information found in several databases, researchers are able to analyze a 
single, comprehensive data source that includes information on patient diagnoses, 
provider services, utilization of resources and socio-demographic characteristics (56).  
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There are many advantages to using administrative data and/or claims data as opposed 
to specially-collected data: cost (most of the time, it is considerably less expensive to 
use pre-existing data than to collect new data), large sample size (traditionally this type 
of data will cover an entire population), and relative freedom from bias (this type of data 
was collected blindly without any specific hypotheses in mind) (44, 56).   
Use of administrative and/or claims data is not without its limitations.  Primarily, 
this data was not collected with research in mind, consequently many variables that are 
important to researchers are not included as they were not important for the 
administrators that originally collected the data (44).  Additionally, due to privacy 
concerns, researchers are often limited in their ability to access this type of data and with 
what they are able to do with this type of data (44).  Furthermore, there may be valid 
concerns regarding the accuracy of this type of data.  A study conducted in the United 
States found that of 348 physician visits, physicians made an incorrect primary 
diagnosis 15% of the time, forms where the data was recorded were missing 8% of the 
time, and data was entered incorrectly 22% of the time (57).  It is important to note that 
of the three sites where this study occurred, only one site used a partial fee-for-service 
payment mechanism.  It is possible that when physicians’ income depends on the quality 
of the data they submit they may have more incentive to accurately record what was 
done and what the diagnosis was (57).  Furthermore, this particular study only allowed 
the physicians one visit to make an accurate diagnosis (57).  It is possible that if a 
physician saw a patient on a regular basis s/he would have the opportunity to review 
previous diagnoses, re-assess the patient’s condition, and make the correct diagnosis on 
a subsequent visit (57).   
 29
While limitations of this type of data source need to be kept in mind when 
utilizing this type of data, researchers can take steps to minimize the potential for error 
in the data they receive by linking databases, examining comorbidities and prior use of 
health care services to partially account for severity of illness, and use of statistical 
methods such as imputation to account for missing data (56).  Studies have been done 
specifically examining the reliability of the data contained in the Saskatchewan Health 
data banks.  One such study examined the reliability of the recording of hysterectomies 
in the hospitalization data files and in the clinical charts (58).  This study concluded that 
the health care utilization files maintained by Saskatchewan Health act as a valid source 
of data for both research and evaluation studies (58).
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CHAPTER THREE: METHODOLOGY 
 
This chapter will describe the materials and methods used in this study.  It will begin by 
describing the study population, the study design, and the study variables before 
continuing on to the analysis plan.   
3.1 Study Population 
This study follows 17,414 children (9169 cases and 8245 controls) born between 
January 1, 1994 to December 31, 1998 from birth until their fifth birthday (1827 days).  
Children remained in the study until their fifth birthday, death, or emigration out of 
Saskatchewan, whichever event occurred first.  All live born children in Saskatchewan 
with a congenital anomaly in the aforementioned time period were included in the case 
group.  A CA was defined as the presence of an International Classification of Disease, 
Version 9 (ICD-9) code between 740 and 759, a Medical Services Branch (MSB) code 
of 60 or 61, or an International Classification of Disease, Version 10 (ICD-10) code 
between Q00 and Q99 (please see Appendix A for a list of included codes) that was 
diagnosed at anytime prior to the child’s fifth birthday.  Four hundred sixty-nine (469) 
children eligible for inclusion as controls in the birth cohort had CAs that were 
diagnosed after their fifth birthday and were not included in the study as either cases or 
controls.  During the follow-up period, use of physician services and hospital services 
were tracked through routinely collected health administrative data and physician billing 
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data.  The length of stay in hospital was derived by subtracting the date of admission 
from the date of discharge. 
3.2 Study Design 
This is a retrospective cohort study that involves the use of individual level variables.  In 
a cohort study, the researcher follows a group of exposed individuals (i.e. those with 
congenital anomalies) and unexposed individuals (i.e. those without congenital 
anomalies) and follows both groups for a period of time to compare the incidence of 
disease (or in this particular case, utilization of health care services) in both groups (59).  
This particular study is more complicated than a typical cohort study would be because 
of the number of outcome variables.  In addition to examining the differential utilization 
of health care services between children with and without congenital anomalies, this 
research is also attempting to examine regional differences in health care utilization for 
children with and without congenital anomalies.   
 This study uses data from administrative health databases maintained by 
Saskatchewan Health.  A matching with replacement selection process was used to 
match controls to cases based on Regional Health Authority of residence at birth, 
gender, Registered Indian status and year of birth.  Matching is the process of equalizing 
the distribution of selected factors within study populations (i.e. the case population and 
the control population), and is used frequently to control for selection bias in both cohort 
and case-control studies (60).  In cohort studies, matching has two main functions: first 
it can be used to control confounding, and second it can be used to increase the 
efficiency of the study (60).  While there can be many drawbacks associated with 
matching in case-control studies, there are fewer drawbacks in cohort studies because 
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the matching process is independent of the outcome under study (i.e. use of health care 
services) (60).  In this particular study, one-to-one matching with replacement was used, 
meaning that for each case, one matched control was selected from all live births 
between January 1, 1994 to December 31, 1998.  Matching with replacement means that 
once a control was selected for a particular case, it was put back into the pool of eligible 
controls and therefore was available to be randomly selected as a control for another 
case.  Because of this matching process, 9169 controls are used in the analysis instead of 
the 8245 individual controls as some controls were matched to more than one case. 
3.3 Data Sources 
Data was obtained from the following Saskatchewan Health databases: Health Insurance 
Registration File (a.k.a. Population Registry, Person Registry System), Vital Statistics, 
Hospital Separations, and Physician Claims. 
 Through the process of administering a publicly funded health care system 
Saskatchewan Health has accumulated a large amount of administrative health care data 
that has been used for over one hundred studies (61).  The Population Registry contains 
information on all individuals who are eligible for Saskatchewan Health benefits (the 
covered population) and is updated daily for name and address changes, births, deaths, 
receipt of social assistance, new residents and departing residents from the province 
(61).   
 Vital statistics data includes information on all births, deaths, stillbirths and 
marriages for Saskatchewan Health beneficiaries (61).  Live birth registration is the 
responsibility of the family and includes both obstetrical and infant information (61). 
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As all Saskatchewan Health beneficiaries are eligible to receive medically 
necessary hospital services without charge, Saskatchewan Health is able to collect 
hospital services data from all hospitals in Saskatchewan; this includes all acute care in-
patient hospital separations, in-patient psychiatric separations and day surgeries (61).  
Information on out-of-province hospital separations is also captured for individuals with 
Saskatchewan HSNs; however, the level of detail may not be the same as for in-
province hospital separations (61).   
Since 1979, medical services diagnoses have been reported according to the 
International Classification of Diseases, Ninth Revision (ICD-9) coding scheme and 
procedures were coded according to the Canadian Classification of Diagnostic, 
Therapeutic and Surgical Procedures (CCP) guidelines (61).  As of April 2002, 
diagnoses are coded according to the International Statistical Classification of Diseases 
and Related Health Problems, Tenth Revision, Canada (ICD-10-CA) guidelines, and 
procedures are recorded using the Canadian Classification of Health Interventions (CCI) 
coding scheme (61). 
In addition to hospital benefits, members of the covered population are also 
eligible to receive benefits for insured medical services without charge (61).  These 
benefits include: anesthesia, diagnostic services, obstetrical services and surgical 
services; however, there are some medical services (e.g. cosmetic surgery, examinations 
for insurance and/or employment purposes) that are not insured (61).  Medical services 
data is based on physicians’ claims for payment under a fee-for-service payment plan 
(61).  While there are a number of physicians in Saskatchewan who fall under an 
alternative payment plan (i.e. salary, contract), unless they choose to shadow or dummy 
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bill Saskatchewan Health for the services they provide, this information will not be 
captured in this database (61).  Additionally, medical services from non-physicians (i.e. 
nurse practitioners) will not be captured in this database.   
Data was abstracted from the abovementioned databases by Saskatchewan 
Health personnel, linked by health services number and de-identified prior to its release.   
3.4 Study Variables 
Table 3.1 describes the variables used in this particular study.  Cut points for categorical 
variables were selected based on their clinical significance, definitions found in the 
literature and data availability.  Predictor variables are grouped by characteristics related 
to need, predisposing factors and enabling factors as per Anderson’s model for the 
determinants of health care utilization (11).   
Table 3.1: Description of study variables 
Predictor Variables Description Variable Coding 
Need Characteristics 
Congenital Anomaly 
Status 
This is a dichotomous variable, with 
children who do not have any congenital 
anomalies being coded as ‘0’ and 
children who have at least one congenital 
anomaly being coded as ‘1’.   
No (ref)  
Yes 
Multiple Congenital 
Anomaly Status 
This is a derived dichotomous variable, 
with children who have at least two 
congenital anomalies being coded as ‘1’ 
and all other children being coded as ‘0’.  
No (ref) 
Yes 
Type of Congenital 
Anomaly 
This is a series of 22 dichotomous 
variables (ICD-9 740-759, MSB 60-61) 
which indicate the specific congenital 
anomaly the child has.  Children who do 
not have that particular congenital 
anomaly are coded as ‘0’, and children 
who do have that particular congenital 
anomaly are coded as ‘1’. 
 
 
 
 
No (ref) 
Yes 
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Birth Weight This is a categorical variable with 6 
values: ‘1’ for a birth weight of less than 
1000g, ‘2’ for a birth weight of 1000-
1499g, ‘3’ for a birth weight of 1500-
1999g, ‘4’ for a birth weight of 2000-
2499g, ‘5’ for a birth weight of 2500-
3999g, and ‘6’ for a birth weight of 
4000g or higher. 
<1000g (ref) 
1000g-1499g 
1500g-1999g 
2000g-2499g 
2500g-3999g 
≥4000g 
Gestational Age This is a categorical variable with 4 
levels: ‘1’ for a gestational age of less 
than 28 weeks (very pre-term), ‘2’ for a 
gestational age of 28-36 weeks (pre-
term), ‘3’ for a gestational age of 37-41 
weeks (term), and ‘4’ for a gestational 
age of 42 weeks or more (post-term). 
< 28 weeks (ref) 
28-36 weeks 
37-41 weeks 
≥42 weeks 
Predisposing Characteristics 
Baby's Sex This is a dichotomous variable, with 
males coded as ‘1’ and females coded as 
‘2’. 
Male (ref)  
Female 
Registered Indian 
Status 
This is a dichotomous variable, with 
Registered Indians being coded as ‘1’, 
and the general population being coded 
as ‘0’.  Please note that this is not an 
accurate reflection of Aboriginal status as 
many individuals who would self-
identify as Aboriginal (i.e. Métis) do not 
qualify for Registered Indian status (32).  
No (ref) 
Yes 
Mother's Age Group This is a categorical variable with 3 
levels that indicates the mother’s age 
group at the time of the child’s birth.  
Mothers who were less than 20 years old 
at the time of the baby’s birth were coded 
as ‘1’, mothers who were between the 
ages of 20 and 34 when their babies were 
born were coded as ‘2’, and mothers who 
were 35 years of age or older when their 
babies were born were coded as ‘3’. 
< 20 (ref) 
20-34 
≥35 
Mother's Marital 
Status 
This is a categorical variable with 3 
levels that indicates the mother’s marital 
status at the time of the child’s birth.  
Mothers who were single were coded as 
‘1’, mothers who were married or in a 
common law relationship were coded as 
‘2’.  All mothers for whom this 
information was not available were coded 
as ‘3’ for other. 
Single (ref) 
Married/Common 
Law 
Other 
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Parity This is a categorical variable with 5 
levels that measures the combined 
number of live births and stillbirths 
(please note that the birth of this child is 
included in this number, i.e. if this is a 
first child, the parity would equal 1).  
First time mothers were coded as ‘1’, 
mothers who had given birth twice were 
coded as ‘2’, mothers who had given 
birth three times were coded as ‘3’, 
mothers who had given birth four times 
were coded as ‘4’, and mothers who had 
given birth five or more times were 
coded as 5.  Please note that this variable 
is not able to distinguish between live 
births and stillbirths. 
1 (ref) 
2 
3 
4 
≥5 
Number of Times 
Mother is Enrolled 
in the Study 
This is a continuous variable ranging 
from 1-4 that measures the number of 
times the mother is enrolled in the study.  
1 (ref) 
2 
3 
4 
Enabling Characteristics 
RHA of Residence This is a series of 5 categorical variables 
that indicate in which RHA the child 
lived as of December 31st of each year 
the child was enrolled in the study.  
Individuals living in Saskatoon were 
coded as ‘1’, individuals living in Five 
Hills were coded as ‘2’, individuals 
living in Cypress were coded as ‘3’, 
individuals living in Regina Qu’Appelle 
were coded as ‘4’, individuals living in 
Sunrise were coded as ‘5’, individuals 
living in Heartland were coded as ‘7’, 
individuals living in Kelsey Trail were 
coded as ‘8’, individuals living in Prince 
Albert Parkland were coded as ‘9’, 
individuals living in Prairie North were 
coded as ‘10’, individuals living in Sun 
Country were coded as ‘11’ and 
individuals living in Northern 
Saskatchewan (Mamawetan Churchill 
River, Keewatin Yatthé, and Athabasca) 
were coded as ‘99’. 
 
 
 
Saskatoon (ref)  
Sun Country  
Five Hills 
Cypress 
Regina Qu’Appelle 
Sunrise 
Heartland 
Kelsey Trail 
PA Parkland 
Prairie North 
Northern 
Saskatchewan 
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Family Received 
Income Assistance 
This is a series of 6 dichotomous 
variables that indicate whether or not the 
child’s family was receiving some form 
of government income assistance as of 
December 31st.  This variable is 
measured separately for each of the five 
years of follow-up and a derived variable 
was created to measure whether or not a 
family had ever received government 
income assistance.  Families that had 
received income assistance were coded as 
‘1’ and families that had not received 
income assistance were coded as ‘0’.  
Please note that this variable does not 
capture families that had received income 
assistance during the year, but were not 
currently receiving income assistance as 
of December 31st. 
No (ref)   
Yes 
Travel for Physician 
Visits 
This is a series of 8 dichotomous derived 
variables that measure whether or not a 
child traveled outside of his/her home 
RHA for a physician visit in another 
RHA during the first 7 days, the first 28 
days, the first year, the second year, the 
third year, the fourth year, the fifth year, 
or at any point in time during the study 
period.  Children who did not travel 
outside of their home RHA for a 
physician visit were coded as ‘0’, and 
children who did travel outside of their 
home RHA for a physician visit were 
coded as ‘1’. 
No (ref) 
Yes 
Travel for 
Hospitalization 
This is a series of 8 dichotomous derived 
variables that measure whether or not a 
child was admitted to a hospital outside 
of his/her home RHA during the first 7 
days, the first 28 days, the first year, the 
second year, the third year, the fourth 
year, the fifth year, or at any point in time 
during the study period.  Children who 
were not hospitalized outside of their 
home RHA were coded as ‘0’, and 
children who were hospitalized outside of 
their home RHA were coded as ‘1’. 
 
 
No (ref) 
Yes 
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Child Moved to 
Another RHA 
This is a derived dichotomous variable 
that indicates whether or not a child 
moved to at least one other RHA during 
their enrollment in the study (i.e. as of 
December 31st they were living in a 
different RHA than at December 31st of 
the previous year).  Children who had not 
moved were coded as ‘0’ and children 
that had moved at least once were coded 
as ‘1’.  Please note, this variable does not 
account for multiple moves to other 
RHAs within the course of one calendar 
year, or moves within RHAs. 
No (ref)   
Yes 
Follow-Up Time 
Period 
This is a continuous variable, ranging 
from 0 days to 1827 days, that measures 
the number of days the child was enrolled 
in the study. 
Continuous Variable 
Reason for Study 
Exit 
This is a dichotomous variable with a 
value of ‘0’ if the child remained in the 
study until the study was finished and a 
value of ‘1’ if the child exited the study 
due to any form of health coverage 
termination (i.e. emigrated out of 
province or death). 
Study End (ref) 
Health Coverage 
Terminated 
Outcome Variables Description  
Hospital Admissions This is a series of 8 count variables, 
ranging from 0-67, that indicates the 
number of hospital admissions in the first 
7 days, the first 28 days, the first year, 
the second year, the third year, the fourth 
year, the fifth year, or at any point in time 
during the study period. 
Count Variable 
Physician Visits This is a series of 8 count variables, 
ranging from 0-713, that indicates the 
number of physician visits in the first 7 
days, the first 28 days, the first year, the 
second year, the third year, the fourth 
year, the fifth year, or at any point in time 
during the study period. 
Count Variable 
Length of Stay This is a count variable that ranges from 
0-779, that indicates the total length of 
stay in hospital during the study period. 
Count Variable 
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3.5 Ethics Approval and Confidentiality 
This study was approved by the University of Saskatchewan Behavioural Ethics Review 
Committee (BEH #05-159, 2005).  De-identified individual record level data and 
aggregate data were forwarded to the researcher from Saskatchewan Health following 
approval from Saskatchewan Health’s Data Access Review Committee (DARC).  All 
results are be reported at the RHA or provincial level, and a minimum cell size of five 
(5) was used for all analyses. 
3.6 Software Used 
A variety of software packages were used during the completion of this study: 
• Microsoft Excel (2000) and Microsoft Access (2000) were used for data cleaning 
• SPSS (version 13.0) and STATA (version 9.0) were used for data analysis 
o STATA was used for model building, while SPSS was used for all other 
analyses 
• Excel and SPSS were used to create tables and figures 
• EndNote (version 8.0.2) was used for reference management 
3.7 Data Analysis 
3.7.1 Characteristics of the Study Population 
Frequencies are presented for all predictor variables seen in Table 3.1.  Bivariate 
analyses were used to compare the distribution of predictor variable for children with 
and without congenital anomalies.  One way ANOVAs were used to compare 
continuous variables and chi squares were used to compare categorical variables 
3.7.2 Regional Differences in the Prevalence of Congenital Anomalies 
Prevalence of CAs is defined as the proportion of children with a birth defect in 
Saskatchewan that were born between January 1, 1994 to December 31, 1998 (62).  As 
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many birth defects lead to early embryonic death, which, if even recognized, is often 
classified as a miscarriage instead of a birth (either live or still), the number of children 
with CAs at birth is only a  small proportion of all affected embryos (62).  Hence, when 
studying CAs, prevalence is used as the standard measure of disease frequency instead 
of incidence (62). 
When calculating the prevalence of CAs, children with multiple CAs were 
counted as one, but when calculating the prevalence of specific CAs, children with 
multiple CAs were counted for each type of CA they are affected by (63).  Graphical 
analysis was used to assess regional differences in the overall prevalence of CAs and 
regional differences in specific types of CAs.  The Saskatoon Health Region was 
selected as the reference category for all regional comparisons for a number of reasons.  
Foremost, is that the Saskatoon Health Region has the most tertiary care centres in 
Saskatchewan.  Additionally, it has the largest population of all of the regional health 
authorities, and due to more resources this population is the most studied.  Finally, the 
Saskatoon Health Region is used as a reference category in many Saskatchewan Health 
reports. 
3.7.3 Study Question 1: Is the Level of Health Care Used by Children With 
Congenital Anomalies Significantly Different from the Level of Health Care Used 
by Children Without Congenital Anomalies?   
One way ANOVAs were used to compare each of the three outcome variables for 
children with and without CAs, and for children with specific types of CAs versus 
children without CAs. 
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3.7.4 Study Question 2: Is There a Regional Difference in the Level of Health Care 
Used by Children in their First Five Years of Life?  And Does This Relationship 
Hold For Children With and Without CAs? 
One way ANOVAs and Bonferroni post-hoc tests were used to determine whether or not 
there is a crude regional difference in each of the three outcome variables for all 
children in the study, for children with congenital anomalies and for children without 
congenital anomalies.  Additionally, as travel outside of one’s home RHA for health 
care is likely to be a significant confounder of use of health care services, crude regional 
differences in travel for physician visits and for hospitalizations were also assessed 
using one way ANOVAs and Bonferroni post-hoc tests.  For all regional comparisons, 
the Saskatoon Health Region was used as the reference category. 
3.7.5 Study Question 3: What Factors Influence the Level of Health Care 
Utilization? 
Health care utilization is a broad term, and in this particular study encompasses three 
distinct outcome variables: total number of physician visits in the study period, total 
number of hospital admissions in the study period and total length of stay (in days) in 
the study period (see Table 3.1 for a description of these variables).  Since the factors 
that influence the use of these services may differ, each outcome variable was assessed 
separately.  As the outcome variables were based on count data with substantial over-
dispersion, a negative binomial distribution was used to model each of the outcome 
variables (60, 64, 65).  
 All variables were initially included in the model, and variables that were 
statistically significant (p<0.05) were retained as main effects.  As can be seen in Table 
3.1, all variables used in the model were categorical in nature and the first category was 
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left as the default reference category.  If any one of the categories achieved statistical 
significance the entire variable was retained in the model. 
 Once main effects were established for each of the three models, the interaction 
terms seen in Table 3.2 were tested for statistical significance provided that all the 
constituent parts of the interaction terms had already achieved statistical significance.  
Interaction terms were added simultaneously and were retained in the final model if they 
were statistically significant at the alpha is less than 0.05 level.  Interaction terms were 
also treated as categorical variables.  Interaction terms were selected as the literature 
shows that these variables have the biggest known impact on health care utilization.  
Table 3.2: Interaction terms tested in all predictive models for health care utilization 
Interaction Term Description 
RHA*TRAVEL 
 
RHA of Residence in Birth Year x Child Ever Traveled 
Outside of Home RHA for Health Care† 
RI*CA 
 
Congenital Anomaly x Registered Indian Status 
AGE*CA Congenital Anomaly x Mother's Age Group 
SEX*CA Congenital Anomaly x Baby's Sex 
MARITAL*CA Congenital Anomaly x Mother's Marital Status 
MARITAL*AGE Mother's Marital Status  x Mother's Age Group 
† For physician visits model only travel for physician visits was included and for 
hospitalization model and LOS model only travel for hospitalization was included 
 
 After all main effects and interaction terms had been tested for statistical 
significance, a final model was run that only included terms that were statistically 
significant. 
 The odds ratios presented for RHA in the models for health care utilization are 
adjusted for all other factors present in the model. 
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CHAPTER FOUR: RESULTS 
 
This chapter begins by describing the characteristics of the total study population, and 
then separately describes the population of children with congenital anomalies and 
children without congenital anomalies.  It goes on to describe the regional differences in 
birth defects in Saskatchewan prior to presenting the results of the study questions.   
4.1 Description of the Study Population 
As the covariates in this study fall into two general categories – those that do not vary 
over time and those that do vary over time – the results of these types of variables are 
presented separately in Tables 4.1 and 4.2 respectively and in Figures 4.1 through 4.3.  
Table 4.1 presents the descriptive results for all of the covariates that do not vary over 
time for the study population.  For categorical variables, the frequency and the 
percentage are presented for each of the categories, while the mean, median, mode and 
range are presented for the continuous variables.   
Table 4.1: Non-time-varying covariates for the study population (N=18338) 
Predictor Variables Category Frequency (%) 
Need Characteristics 
Congenital Anomaly  Yes
No
9169 (50.0%)
9169 (50.0%)
Multiple Congenital 
Anomalies 
Yes
No
2082 (11.4%)
16256 (88.6%)
Birth Weight <1000g
1000g-1499g
1500g-1999g
2000g-2499g
2500g-3999g
≥4000g
160 (0.9%)
198 (1.1%)
315 (1.7%)
752 (4.1%)
14425 (78.7%)
2488 (13.6%)
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Gestational Age < 28 weeks
28-36 weeks
37-41 weeks
≥42 weeks
165 (0.9%)
1492 (8.1%)
16181 (88.2%)
500 (2.7%)
Predisposing Characteristics 
Baby's Sex Male
Female
10026 (54.7%)
8312 (45.3%)
Registered Indian Status Yes
No
2980 (16.3%)
15358 (83.7%)
Mother's Age Group < 20
20-34
≥35
1915 (10.4%)
14669 (80.0%)
1754 (9.6%)
Mother's Marital Status Single
Married/Common Law
Other
4922 (26.8%)
12238 (66.7%)
1177 (6.4%)
Parity 1
2
3
4
≥5
6377 (34.8%)
6162 (33.6%)
3346 (18.2%)
1383 (7.5%)
1070 (5.8%)
Number of Times Mother is 
Enrolled in the Study 
1
2
3
4
15496 (84.5%)
2695 (14.7%)
143 (0.8%)
4 (0.0%)
Enabling Characteristics 
Child Moved to Another 
RHA 
Yes
No
1202 (6.6%)
17136 (93.4%)
Follow-Up Time Period 
(Days) 
Mean
Median
Mode
Range
1707.12
1826.00
1826
0-1827
Reason for Study Exit Study End
Health Coverage Terminated 
17157 (93.6%)
1181 (6.4%)
 
Table 4.1 indicates that there are more males than females in the study population 
(54.7% vs. 45.3%), and that there are substantially fewer Registered Indians than 
members of the general population (16.3% vs. 83.7%) in the sample.  The percentage of 
Registered Indians in the current study is reflective of the percentage of Registered 
Indians in the total Saskatchewan population.  The majority of infants were born at term 
(37-41 weeks gestational age) (88.2%) and were of a normal birth weight (2500-3999g) 
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for term infants (78.7%).  However, 2.7% of the children enrolled in the study were born 
post-term (gestational age ≥42 weeks), while 8.1% were pre-term (gestational age 
between 28 and 36 weeks) and 0.9% were born very pre-term (< 28 weeks gestational 
age).  As mentioned previously, most of the infants had a normal birth weight for term 
babies; however, 13.6% had a high birth weight (≥4000g for term infants), and 3.7% 
had a very low birth weight (<2000g for term infants).  The remaining 4.1% of infants 
had a low birth weight (2000g-2499g for term infants.  Additionally, over 90% of the 
children were enrolled in the study until the study was finished, with only 6.4% of 
children exiting the study prematurely, either due to death or emigration.  The mean 
number of days of follow-up was 1707.12 days.  
As depicted in Table 4.1, 80.0% of mothers were between the ages of 20 and 34 
at the time of their child’s birth, while 10.4% were teen mothers, and 9.6% were 35 
years of age or older.  At the time of their child’s birth, 66.7% of mothers were married 
or in a common-law relationship, 26.8% were single, and 6.4% were defined by 
Saskatchewan Health as ‘other’.  Eighty-four point five percent (84.5%) of the mothers 
were enrolled in the study once, while 14.7% were included in the study twice as they 
had two children included in the study; the remaining 0.8% were included in the study 
three times.  In this study, the term parity refers to the combined total of all live births 
and stillbirths; however, due to the manner in which data was released for the study it is 
not possible to differentiate between the two.  In this study, 34.8% of mothers were first-
time mothers, while 33.6% had had one previous birth prior to the child that was 
included in the study.  An additional 18.2% of mothers had a parity of three, 7.5% had a 
parity of four and the remaining 5.8% had a parity of five or more. 
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 Table 4.2 and Figures 4.1 to 4.3 describe the covariates that do vary over time 
for the study population.  As the majority of children were enrolled in the study for the 
entire duration of the study, and only 6.6% of children moved to another RHA during 
the study period (see table 4.1) it is not surprising that there is little variability in RHA 
of residence for the duration of the study.  The largest change is in the Regina 
Qu’Appelle health region which saw a decrease of 3.0% over the entire five year time 
period.  Slightly more variability over time is seen with regards to whether or not 
children’s families are receiving some form of governmental income assistance.  This 
changes from a low of 16.8% of all children in the first year of follow-up to a high of 
22.5% in the fifth year of follow-up (resulting in a net increase of 5.7%).  Each year 
there was a decrease in the number of children who traveled outside of their home RHA 
to obtain physician care or for hospitalizations. 
Table 4.2: RHA of residence for the study population by year (N=18338) 
  Frequency (%) 
Predictor 
Variables 
Category 1st 
Year 
2nd 
Year 
3rd Year 4th Year 5th Year Ever 
Enabling Characteristics 
Sun Country 892 
(4.9%) 
859 
(4.7%) 
853 
(4.7%) 
846 
(4.6%) 
840 
(4.6%) 
N/A 
Five Hills 953 
(5.2%) 
921 
(5.0%) 
897 
(4.9%) 
878 
(4.8%) 
850 
(4.6%) 
N/A 
Cypress 468 
(2.6%) 
455 
(2.5%) 
444 
(2.4%) 
444 
(2.4%) 
430 
(2.3%) 
N/A 
Regina 
Qu’Appelle 
5244 
(28.6%) 
5057 
(27.6%) 
4926 
(26.9%) 
4799 
(26.2%) 
4700 
(25.6%) 
N/A 
Sunrise 946 
(5.2%) 
902 
(4.9%) 
881 
(4.8%) 
866 
(4.7%) 
865 
(4.7%) 
N/A 
Saskatoon 5039 
(27.5%) 
4881 
(26.6%) 
4791 
(26.1%) 
4642 
(25.3%) 
4568 
(24.9%) 
N/A 
Heartland 669 
(3.6%) 
647 
(3.5 %) 
655 
(3.6%) 
651 
(3.6%) 
639 
(3.5%) 
N/A 
 
 
 
 
 
 
 
 
 
 
 
RHA of 
Residence 
Kelsey Trail 621 
(3.4%) 
618 
(3.4%) 
599 
(3.3%) 
606 
(3.3%) 
616 
(3.4%) 
 
N/A 
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PA Parkland 1369 
(7.5%) 
1331 
(7.3%) 
1308 
(7.1%) 
1294 
(7.1%) 
1265 
(6.9%) 
N/A 
Prairie 
North 
1310 
(7.1%) 
1241 
(6.8%) 
1185 
(6.5%) 
1139 
(6.2%) 
1112 
(6.1%) 
N/A 
Northern 
Sask 
827 
(4.5%) 
785 
(4.3%) 
759 
(4.1%) 
745 
(4.1%) 
732 
(4.0%) 
N/A 
Missing 0 
(0.0%) 
641 
(3.5%) 
1040 
(5.7%) 
1428 
(7.8%) 
1721 
(9.4%) 
N/A 
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Figure 4.1: Percentage of families receiving income assistance by year in the study 
population 
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Figure 4.2: Percentage of children who traveled outside of their home RHA for a 
physician visit by year 
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Figure 4.3: Percentage of children who traveled outside of their home RHA for a 
hospital admission by year 
 
 The prevalence per 1000 live births of different types of congenital anomalies in 
the study population can be seen in Figure 4.4 (see Appendix A for more detail 
regarding what specific CAs make up each larger category of CAs).  Figure 4.5 
illustrates the prevalence per 1000 live births of the broader categories of CAs seen in 
the study population.
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Figure 4.4: Prevalence of congenital anomalies in the study population per 1000 live 
births 
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Figure 4.5: Prevalence of categories of CAs in the study population 
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4.2 Bivariate Analysis by Congenital Anomaly Status 
As congenital anomaly status (the presence or absence of at least one congenital 
anomaly) is the principal covariate in this study, bivariate analyses were conducted to 
examine the differences in baseline characteristics between children with birth defects 
and children without birth defects.  Please note that children with and without birth 
defects were matched on year of birth, sex, RHA of residence in their first year and 
Registered Indian status, so no variability will be present for these categories. 
 Table 4.3 illustrates the differences and similarities between children with and 
without birth defects for predictor variables that do not vary over time.  Pearson χ2 tests 
were used to assess differences between groups for categorical variables and one-way 
ANOVAs were used to assess differences between groups for continuous variables. 
Table 4.3: Non-time-varying predictor variables for children with congenital anomalies 
(N=9169) and children without congenital anomalies (N=9169) 
 
Predictor 
Variables 
 
Category 
Children 
with  
Congenital 
Anomalies 
Frequency (%) 
Children 
without 
Congenital 
Anomalies 
Frequency (%) 
 
Statistical Test 
(significance 
level) 
Need Characteristics 
Birth 
Weight 
<1000g
1000g-1499g
1500g-1999g
2000g-2499g
2500g-3999g
≥4000g
157 (1.7%)
177 (1.9%)
248 (2.7%)
509 (5.6%)
6869 (74.9%)
1209 (13.2%)
3 (0.0%) 
21 (0.2%) 
67 (0.7%) 
243 (2.7%) 
7556 (82.4%) 
1279 (13.9%) 
χ2 = 503.916 
(<0.001)* 
Gestational 
Age 
< 28 weeks
28-36 weeks
37-41 weeks
≥42 weeks
160 (1.7%)
1020 (11.1%)
7748 (84.5%)
241 (2.6%)
5 (0.1%) 
472 (5.1%) 
8433 (92.0%) 
259 (2.8%) 
χ2 = 376.529 
(<0.001)* 
Predisposing Characteristics 
Baby's Sex Male
Female
5013 (54.7%)
4156 (45.3%)
5013 (54.7%) 
4156 (45.3%) 
Matched 
Variable 
Registered 
Indian 
Status  
 
Yes
No
1490 (16.3%)
7679 (83.7%)
1490 (16.3%) 
7679 (83.7%) 
Matched 
Variable 
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Mother's 
Age Group 
< 20
20-34
≥35
958 (10.4%)
7298 (79.6%)
913 (10.0%)
957 (10.4%) 
7371 (80.4%) 
841 (9.2%) 
χ2 = 3.319 
(0.190) 
Mother's 
Marital 
Status 
Single
Married/Common 
Law
Other
2525 (27.5%)
6020 (65.7%)
623 (6.8%)
2397 (26.1%) 
6218 (67.8%) 
 
554 (6.0%) 
χ2 = 10.577 
(0.005)* 
Parity 1
2
3
4
≥5
3385 (36.9%)
3050 (33.3%)
1523 (16.6%)
679 (7.4%)
532 (5.8%)
2992 (32.6%) 
3112 (33.9%) 
1823 (19.9%) 
704 (7.7%) 
538 (5.9%) 
χ2 = 52.227 
(<0.001)* 
Number of 
Times 
Mother is 
Enrolled in 
the Study 
1
2
3
4
7657 (83.5%)
1426 (15.6%)
82 (0.9%)
4 (0.0%)
7839 (85.5%) 
1269 (13.8%) 
61 (0.7%) 
0 (0.0%) 
χ2 = 18.368 
(<0.001)* 
Enabling Characteristics 
Child 
Moved to 
Another 
RHA 
Yes
No
633 (6.9%)
8536 (93.1%)
569 (6.2%) 
8600 (93.8%) 
χ2 = 3.647 
(0.056) 
Follow-Up 
Time 
Period 
(Days) 
Mean
Median
Mode
Range
1697.93
1826.00
1826
0-1827
1716.31 
1826.00 
1826 
0-1827 
F = 10.371 
(0.001)* 
Reason for 
Study Exit 
Study End
Health Coverage 
Terminated 
8060 (87.9%)
1109 (12.1%)
9097 (99.2%) 
72 (0.8%) 
χ2 = 973.236 
(<0.001)* 
* Statistically Significant 
† Matched Variables 
 
For the majority of predictor variables there is a statistically significant difference 
between children with and without congenital anomalies, many of which can be 
explained by the presence or absence of the anomaly.  The early detection of certain 
CAs may result in the attending physician inducing labour which can in turn result in a 
lower birth weight and gestational age.  Also, significantly more children with birth 
defects left the study earlier than children without birth defects.  While the specific 
reason why each individual child left the study is unknown, the difference could at least 
 52
in part be explained by the higher risk of early death for children with serious birth 
defects versus children without a birth defect, or the need to emigrate out of province to 
a larger centre where more specialized care can be offered.  Finally, as children with at 
least one birth defect were more likely to leave the study prematurely than children 
without any birth defects, it is not surprising that children with birth defects have a 
shorter mean length of follow-up than children without birth defects.  While there is also 
a statistically significant difference between children with and without birth defects for 
maternal characteristics, these differences cannot be easily explained due to the presence 
or absence of an anomaly. 
 Table 4.4 shows the differences and similarities between children with and 
without birth defects for time-varying predictor variables.  Pearson χ2 tests were used to 
assess differences between groups for categorical variables. 
Table 4.4: Comparison of time-varying predictor variables for children with congenital 
anomalies (N=9169) and children without congenital anomalies (N=9169) 
   Frequency (%) 
Predictor 
Variables 
CA 
Status 
Category 1st  
Year 
2nd Year 3rd  
Year 
4th Year 5th Year Ever
Enabling Characteristics 
Sun 
Country 
446 
(4.9%) 
432 
(4.7%) 
432 
(4.7%) 
425 
(4.6%) 
423 
(4.6%) 
N/A 
Five Hills 476 
(5.2%) 
464 
(5.1%) 
443 
(4.8%) 
429 
(4.7%) 
421 
(4.6%) 
N/A 
Cypress 234 
(2.6%) 
224 
(2.4%) 
218 
(2.4%) 
216 
(2.4%) 
207 
(2.3%) 
N/A 
Regina 
Qu’Appelle
2622 
(28.6%) 
2513 
(27.4%) 
2449 
(26.7%) 
2381 
(26.0%) 
2316 
(25.3%) 
N/A 
Sunrise 472 
(5.1%) 
448 
(4.9%) 
432 
(4.7%) 
427 
(4.7%) 
426 
(4.6%) 
N/A 
Saskatoon 2521 
(27.5%) 
2444 
(26.7%) 
2395 
(26.1%) 
2320 
(25.3%) 
2283 
(24.9%) 
N/A 
Heartland 335 
(3.7%) 
325 
(3.5 %) 
326 
(3.6%) 
326 
(3.6%) 
323 
(3.5%) 
N/A 
Kelsey 
Trail 
310 
(3.4%) 
311 
(3.4%) 
299 
(3.3%) 
301 
(3.3%) 
308 
(3.4%) 
N/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RHA of 
Residence 
 
 
 
 
Children 
With 
CAs 
PA 
Parkland 
685 
(7.5%) 
658 
(7.2%) 
649 
(7.1%) 
638 
(7.0%) 
618 
(6.7%) 
N/A 
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Prairie 
North 
655 
(7.1%) 
612 
(6.7%) 
594 
(6.5%) 
562 
(6.1%) 
557 
(6.1%) 
N/A 
Northern 
Sask 
413 
(4.5%) 
395 
(4.3%) 
373 
(4.1%) 
374 
(4.1%) 
360 
(3.9%) 
N/A 
Missing 0 
(0.0%) 
343 
(3.7%) 
559 
(6.1%) 
770 
(8.4%) 
927 
(10.1%) 
N/A 
Sun 
Country 
446 
(4.9%) 
427 
(4.7%) 
421 
(4.6%) 
421 
(4.6%) 
417 
(4.5%) 
N/A 
Five Hills 477 
(5.2%) 
457 
(5.0%) 
454 
(5.0%) 
449 
(4.9%) 
429 
(4.7%) 
N/A 
Cypress 234 
(2.6%) 
231 
(2.5%) 
226 
(2.5%) 
228 
(2.5%) 
223 
(2.4%) 
N/A 
Regina 
Qu’Appelle
2622 
(28.6%) 
2544 
(27.7%) 
2477 
(27.0%) 
2418 
(26.4%) 
2384 
(26.0%) 
N/A 
Sunrise 474 
(5.2%) 
454 
(5.0%) 
449 
(4.9%) 
439 
(4.8%) 
439 
(4.8%) 
N/A 
Saskatoon 2518 
(27.5%) 
2437 
(26.6%) 
2396 
(26.1%) 
2322 
(25.3%) 
2285 
(24.9%) 
N/A 
Heartland 334 
(3.6%) 
322 
(3.5 %) 
329 
(3.6%) 
325 
(3.5%) 
316 
(3.4%) 
N/A 
Kelsey 
Trail 
311 
(3.4%) 
307 
(3.3%) 
300 
(3.3%) 
305 
(3.3%) 
308 
(3.4%) 
N/A 
PA 
Parkland 
684 
(7.5%) 
673 
(7.3%) 
659 
(7.2%) 
656 
(7.2%) 
647 
(7.1%) 
N/A 
Prairie 
North 
655 
(7.1%) 
629 
(6.9%) 
591 
(6.4%) 
577 
(6.3%) 
555 
(6.1%) 
N/A 
Northern 
Sask 
414 
(4.5%) 
390 
(4.3%) 
386 
(4.2%) 
371 
(4.0%) 
372 
(4.1%) 
N/A 
 
 
 
Children 
Without 
CAs 
Missing 0 
(0.0%) 
298 
(3.3%) 
481 
(5.2%) 
658 
(7.2%) 
794 
(8.7%) 
N/A 
χ2 (sig. 
level) 
 Matched 
Variable 
0.789 
(1.000) 
0.879 
(1.000) 
0.997 
(1.000) 
1.771 
(0.998) 
 
 
 
Children 
With 
CAs 
Yes 
 
No 
 
Missing
1614 
(17.6%) 
7555 
(82.4%) 
0 
(0.0%) 
1788 
(19.5%) 
7038 
(76.8%) 
343 
(3.7%) 
1931 
(21.1%) 
6679 
(72.8%) 
559 
(6.1%) 
2002 
(21.8%) 
6397 
(69.8%) 
770 
(8.4%) 
2130 
(23.2%) 
6112 
(66.7%) 
927 
(10.1%) 
3237 
(35.3
%) 
5932 
(64.7
%) 
0 
(0.0
%) 
 
 
Family 
Received 
Income 
Assistance 
 
Children 
Without 
CAs 
Yes 
 
No 
 
Missing
1464 
(16.0%) 
7705 
(84.0%) 
0 
(0.0%) 
1572 
(17.1%) 
7299 
(79.6%) 
298 
(3.3%) 
1719 
(18.7%) 
6969 
(76.0%) 
481 
(5.2%) 
1881 
(20.5%) 
6630 
(72.3%) 
658 
(7.2%) 
1993 
(21.7%) 
6382 
(69.6%) 
794 
(8.7%) 
3016 
(32.9
%) 
6153 
(67.1
%) 
0 
(0.0
%) 
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χ2 (sig. 
level) 
8.784  
(0.003) 
* 
18.523 
(<0.001)
* 
18.124 
(<0.001) 
* 
7.196 
(0.007) 
* 
9.323 
(0.002) 
* 
11.85
2 
(0.00
1) 
* 
 
Children 
With 
CAs 
Yes 
 
No
4213 
(45.9%) 
4956 
(54.1%) 
3049 
(33.3%) 
6120 
(33.7%) 
2480 
(27.0%) 
6689 
(73.0%) 
2199 
(24.0%) 
6970 
(76.0%) 
2031 
(22.2%) 
7138 
(77.8%) 
5909 
(64.4
%) 
3260 
(35.6
%) 
 
Children 
Without 
CAs 
Yes 
 
No
2718 
(29.6%) 
6451 
(70.4%) 
2097 
(22.9%) 
7072 
(77.1%) 
1681 
(18.3%) 
7488 
(81.7%) 
1524 
(16.6%) 
7645 
(83.4%) 
1435 
(15.7%) 
7734 
(84.3%) 
4547 
(49.6
%) 
4622 
(50.4
%) 
 
 
 
Travel for 
Physician 
Visits 
χ2 (sig. 
level) 
518.402 
(<0.001)
* 
244.819 
(<0.001)
* 
198.456 
(<0.001) 
* 
153.556 
(<0.001)
* 
126.371 
(<0.001)
* 
412.7
66 
(<0.0
01)* 
 
Children 
With 
CAs 
Yes 
 
No
2391 
(26.1%) 
6778 
(73.9%) 
692 
(7.5%) 
8477 
(92.5%) 
443 
(4.8%) 
8726 
(95.2%) 
351 
(3.8%) 
8818 
(96.2%) 
330 
(3.6%) 
8839 
(96.4%) 
2982 
(32.5
%) 
6187 
(67.5
%) 
 
Children 
Without 
CAs 
Yes 
 
No
1449 
(15.8%) 
7720 
(84.2%) 
251 
(2.7%) 
8918 
(97.3%) 
157 
(1.7%) 
9012 
(98.3%) 
149 
(1.6%) 
9020 
(98.4%) 
131 
(1.4%) 
9038 
(98.6%) 
1796 
(19.6
%) 
7373 
(80.4
%) 
 
 
 
Travel for 
Hospital 
Admission 
χ2 (sig. 
level) 
292.290 
(<0.001)
* 
217.417 
(<0.001)
* 
140.938 
(<0.001) 
* 
83.895 
(<0.001)
* 
88.118 
(<0.001)
* 
398.1
21 
(<0.0
01)* 
* Statistically Significant 
 
As seen in Table 4.4, there is not a statistical difference in RHA of residence between 
children with and without CAs for any of the five years of follow-up.  However, there is 
a statistically significant difference for the other three time-varying predictors for each 
of the five years of follow-up.  Table 4.4 shows that the families of children with birth 
defects are more likely to be receiving some form of governmental social assistance, and 
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that these children travel outside of their home RHA for physician visits and for 
hospitalizations more frequently than children without birth defects. 
4.3 Regional Differences in the Prevalence of Congenital Anomalies 
Figure 4.6 illustrates the difference in the prevalence of congenital anomalies per 1000 
live births per region.  While graphical analysis did not reveal an overall difference in 
congenital anomalies by RHA, Table 4.5 and Figures 4.7 through 4.19 illustrate the 
regional differences in specific CAs (see Appendix B for graphs of the mean numbers of 
CAs per RHA).   
Table 4.5: Regional differences in the mean number of cases of CAs compared to the 
Saskatoon Health Region 
ICD-9 
Code 
Variable Description RHAs that are 
Significantly Different 
from Saskatoon 
Figure 
Where Data 
is Presented 
ICD-9 
743 
CAs of the eye 
 
Regina Qu’Appelle  
PA Parkland  
Figure 4.7 
ICD-9 
745 
Bulbus cordis anomalies and 
anomalies of cardiac septal 
closure 
Heartland  
Northern Saskatchewan  
Figure 4.8 
ICD-9 
746 
Other CAs of the heart 
 
PA Parkland  
Prairie North  
Northern Saskatchewan  
Figure 4.9 
ICD-9 
747 
Other CAs of the circulatory 
system 
 
Sun Country  
Cypress  
Regina Qu’Appelle  
Sunrise  
Heartland  
Figure 4.10 
ICD-9 
749 
Cleft lip and cleft palate Northern Saskatchewan  Figure 4.11 
ICD-9 
750 
CAs of the upper alimentary 
tract 
 
Sun Country  
Five Hills  
Cypress  
Regina Qu’Appelle  
Kelsey Trail  
Figure 4.12 
ICD-9 
754 
Certain congenital 
musculoskeletal deformities 
 
 
 
Regina Qu’Appelle  Figure 4.13 
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ICD-9 
755 
Other CAs of limbs 
 
Sun Country  
Five Hills  
Cypress  
PA Parkland  
Prairie North  
Figure 4.14 
ICD-9 
756 
Other musculoskeletal 
anomalies 
Regina Qu’Appelle  Figure 4.15 
ICD-9 
757 
CAs of the integument 
 
Sun Country  
Regina Qu’Appelle  
PA Parkland  
Figure 4.16 
ICD-9 
758 
Chromosomal anomalies Regina Qu’Appelle  
Sunrise  
Figure 4.17 
ICD-9 
759 
Other and unspecified CAs 
 
Sun Country  
Five Hills  
Cypress  
Regina Qu’Appelle  
Sunrise  
Figure 4.18 
MSB Z60 Congenital dysplasia of hip Kelsey Trail  
Prairie North  
Figure 4.19 
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Figure 4.6: Prevalence of any CAs by RHA – No regional differences were found in the 
overall prevalence of birth defects compared to the Saskatoon Health Region (reference 
category). 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.7: Prevalence of CAs of the eye (ICD-9 743) by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.8: Prevalence of bulbus cordis anomalies and anomalies of cardiac septal 
closure (ICD-9 745) by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.9: Prevalence of other CAs of the heart (ICD-9 746) by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.10: Prevalence of other CAs of the circulatory system (ICD-9 747) by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.11: Prevalence of cleft lip and cleft palate (ICD-9 749) by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.12: Prevalence of CAs of the upper alimentary tract (ICD-9 750) by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.13: Prevalence of certain congenital musculoskeletal deformities (ICD-9 754) 
by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.14: Prevalence of other CAs of limbs (ICD-9 755) by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.15: Prevalence of other musculoskeletal anomalies (ICD-9 756) by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.16: Prevalence of CAs of the integument (ICD-9 757) by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.17: Prevalence of chromosomal anomalies (ICD-9 758) by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.18: Prevalence of other and unspecified CAs (ICD-9 759) by RHA 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.19: Prevalence of congenital dysplasia of hip (MSB Z60) by RHA 
4.4 Study Question 1: Is the Level of Health Care Used by Children With 
Congenital Anomalies Significantly Different from the Level of Health Care Used 
by Children Without Congenital Anomalies?   
As indicated in Table 4.6, one-way ANOVAs revealed that at the 5% level of 
significance, there is a statistically significant difference in the number of physician 
visits, the number of hospitalizations and total length of stay by CA status (i.e. child has 
at least one CA). 
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Table 4.6: Differences in use of health care for children with and without congenital 
anomalies 
CA Status Category Total Number 
of Physician 
Visits in the 
first 5 Years 
Total Number 
of 
Hospitalizations 
in the first 5 
Years 
Total  
Length of Stay 
(days) in the 
first 5 Years 
Children 
With 
Congenital 
Anomalies 
Mean
Median
Mode
Range
46.07 
39.00 
31 
0-713 
2.81 
2.00 
1 
0-67 
13.36 
5.00 
3 
0-779 
Children 
Without 
Congenital 
Anomalies 
Mean
Median
Mode
Range
34.07 
30.00 
22 
0-222 
1.83 
1.00 
1 
0-18 
5.31 
3.00 
3 
0-205 
 F statistic
 (significance 
level)
856.674  
 (< 0.001)* 
690.946  
(< 0.001)* 
515.558  
(< 0.001)* 
* Statistically Significant 
 
When the results of Table 4.6 are further broken down into differences between children 
with specific CAs and children without CAs, one way ANOVAs revealed that at the 5% 
level of significance, there is a statistically significant difference in the number of 
physician visits, the number of hospitalizations and length of stay for almost all 
conditions (see Table 4.7).  The most notable exception here is for CAs of the 
integument (ICD-9 757) where children with conditions in this particular class use the 
same level of health care services as children without any CAs for all three measures of 
health care usage. 
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Table 4.7: Differential use of health care services for children with specific types of 
CAs versus children without that particular CA 
 
 
Type of CA 
 
ICD-9 
Code 
Total Number 
of Physician 
Visits 
F statistic 
(significance 
level) 
Total Number 
of 
Hospitalizations 
F statistic 
(significance 
level) 
Total  
Length of 
Stay 
F statistic 
(significance 
level) 
Neural Tube 
Defects 
ICD-9 740 
& ICD-9 
741 
156.779 
(<0.001)* 
276.626 
(<0.001)* 
129.194 
(<0.001)* 
Other congenital 
anomalies of 
nervous system 
ICD-9 742 403.064 
(<0.001)* 
620.860 
(<0.001)* 
592.405 
(<0.001)* 
Congenital 
anomalies of eye 
ICD-9 743 96.847 
(<0.001)* 
60.384 
(<0.001)* 
24.900 
(<0.001)* 
Congenital 
anomalies of ear, 
face, and neck 
ICD-9 744 23.402 
(<0.001)* 
23.800 
(<0.001)* 
2.168  
(0.141) 
Bulbus cordis 
anomalies and 
anomalies of 
cardiac septal 
closure 
ICD-9 745 481.091 
(<0.001)* 
463.171 
(<0.001)* 
715.613 
(<0.001)* 
Other congenital 
anomalies of heart 
ICD-9 746 366.084 
(<0.001)* 
469.535 
(<0.001)* 
576.492 
(<0.001)* 
Other congenital 
anomalies of 
circulatory system 
ICD-9 747 691.150 
(<0.001)* 
586.159 
(<0.001)* 
2472.400 
(<0.001)* 
Congenital 
anomalies of 
respiratory system 
ICD-9 748 170.914 
(<0.001)* 
402.527 
(<0.001)* 
489.525 
(<0.001)* 
Cleft palate and 
cleft lip 
ICD-9 749 149.026 
(<0.001)* 
292.704 
(<0.001)* 
95.632 
(<0.001)* 
Other congenital 
anomalies of upper 
alimentary tract 
ICD-9 750 30.299 
(<0.001)* 
51.254 
(<0.001)* 
2.086  
(0.149) 
Other congenital 
anomalies of 
digestive system 
ICD-9 751 194.283 
(<0.001)* 
368.020 
(<0.001)* 
401.636 
(<0.001)* 
Congenital 
anomalies of 
genital organs 
ICD-9 752 40.953 
(<0.001)* 
26.832 
(<0.001)* 
0.005  
(0.946) 
Congenital 
anomalies of 
urinary system 
ICD-9 753 77.501 
(<0.001)* 
129.859 
(<0.001)* 
69.795 
(<0.001)* 
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Certain congenital 
musculoskeletal 
deformities 
ICD-9 754 69.805 
(<0.001)* 
30.484 
(<0.001)* 
0.102  
(0.749) 
Other congenital 
anomalies of limbs 
ICD-9 755 9.897  
(0.002)* 
0.170  
(0.680) 
7.073  
(0.008)* 
Other congenital 
musculoskeletal 
anomalies 
ICD-9 756 149.397 
(<0.001)* 
72.907 
(<0.001)* 
87.293 
(<0.001)* 
Congenital 
anomalies of the 
integument 
ICD-9 757 1.172  
(0.279) 
1.104  
(0.294) 
0.565  
(0.452) 
Chromosomal 
anomalies 
ICD-9 758 271.152 
(<0.001)* 
275.831 
(<0.001)* 
209.062 
(<0.001)* 
Other and 
unspecified 
congenital 
anomalies 
ICD-9 759 258.947 
(<0.001)* 
254.123 
(<0.001)* 
337.737 
(<0.001)* 
Congenital 
dysplasia of hip 
MSB Z60 3.394  
(0.065) 
1.248  
(0.264) 
6.050  
(0.014)* 
Clubfoot MSB Z61 58.120 
(<0.001)* 
33.247 
(<0.001)* 
14.060 
(<0.001)* 
* Statistically Significant 
4.5 Study Question 2: Is There a Regional Difference in the Level of Health Care 
Used by Children in their First Five Years of Life?  And Does This Relationship 
Hold For Children With and Without CAs? 
4.5.1 Regional Differences in Use of Health Care Services for All Children  
One-way ANOVAs and Bonferroni post-hoc tests revealed that at the 5% level of 
significance there is a crude regional difference in the total number of physician visits 
(F=26.641, p<0.001), hospitalizations (F=34.181, p<0.001) and length of stay (F=9.905, 
p<0.001).  Table 4.8 and Figures 4.20-4.22 provide the results of the post-hoc tests and 
show the specific regional differences when the Saskatoon Health Region is used as a 
reference category. 
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Table 4.8: Crude regional differences in use of health care services 
Variable RHAs that are Significantly 
Different from the Saskatoon 
Health Region (significance 
level) 
Figure Where Data is 
Presented 
Total Number of 
Physician Visits 
Sun Country (0.008) 
Sunrise (<0.001) 
Heartland (<0.001) 
PA Parkland (<0.001) 
Northern Saskatchewan (<0.001) 
Figure 4.20 
Total Number of 
Hospitalizations 
Sun Country (<0.001) 
Five Hills (<0.001) 
Cypress (<0.001) 
Regina Qu’Appelle (<0.001) 
Sunrise (<0.001) 
Kelsey Trail (<0.001) 
PA Parkland (<0.001) 
Prairie North (<0.001) 
Northern Saskatchewan (<0.001) 
Figure 4.21 
Total Length of Stay PA Parkland (<0.001) 
Prairie North (<0.001) 
Northern Saskatchewan (<0.001) 
Figure 4.22 
 
0
5
10
15
20
25
30
35
40
45
50
Cy
pre
ss
Fiv
e H
ills
*H
ea
rtla
nd
Ke
lse
y T
rai
l
*N
ort
he
rn 
Sa
sk
*P
A 
Pa
rkl
an
d
Pr
air
ie 
No
rth
Re
gin
a Q
u'A
pp
ell
e
Sa
sk
ato
on
*S
un
 C
ou
ntr
y
*S
un
ris
e
Sa
sk
atc
he
wa
n
RHA
M
ea
n 
N
um
be
r o
f P
hy
si
ci
an
 V
is
its
 
* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.20: Crude regional differences in the mean number of physician visits in the 
first five years of life compared to the Saskatoon Health Region  
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.21: Crude regional differences in the mean number of hospitalizations in the 
first five years of life compared to the Saskatoon Health Region 
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* Significantly different from the Saskatoon Health Region (reference category) 
 
Figure 4.22: Crude regional difference in the mean length of stay (days) in the first five 
years of life compared to the Saskatoon Health Region 
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With regard to travel to access health care services, one-way ANOVAs indicate that at 
the 5% level of significance, there is a significant difference in number of residents ever 
having to travel outside of their home RHA for a physician visit for all regions when the 
Saskatoon Health Region is used as the reference group (F=372.859, p<0.001) (see 
Table 4.9).  Additionally, as seen in Table 4.9, one-way ANOVAs show that at the 5% 
level of significance, there is a significant difference in the number of residents ever 
having to travel outside of their home RHA for a hospital admission for all regions 
except for Regina Qu’Appelle when the Saskatoon Health Region is used as the 
reference group (F=660.888, p<0.001). 
Table 4.9: Crude regional differences in travel for health care services 
Variable RHAs that are Significantly Different from the 
Saskatoon Health Region (significance level) 
Ever Traveled Outside of 
Home RHA for a Physician 
Visits 
Sun Country (<0.001) 
Five Hills (<0.001) 
Cypress (<0.001) 
Regina Qu’Appelle (<0.001) 
Sunrise (<0.001) 
Heartland (<0.001) 
Kelsey Trail (<0.001) 
PA Parkland (<0.001) 
Prairie North (<0.001) 
Northern Saskatchewan (<0.001) 
Ever Traveled Outside of 
Home RHA for a Hospital 
Admission 
Sun Country (<0.001) 
Five Hills (<0.001) 
Cypress (<0.001) 
Sunrise (<0.001) 
Heartland (<0.001) 
Kelsey Trail (<0.001) 
PA Parkland (<0.001) 
Prairie North (<0.001) 
Northern Saskatchewan (<0.001) 
4.5.2 Regional Differences in Use of Health Care Services for Children With and 
Without Congenital Anomalies 
When use of health care services was considered for children with at least one 
congenital anomaly, one-way ANOVAs and Bonferroni post-hoc tests revealed that at 
 70
the 5% level of significance there is a regional difference in the total number of 
physician visits (F=9.251, p<0.001), hospitalizations (F=18.538, p<0.001) and length of 
stay (F=8.047 , p<0.001).  This is also the case when one exclusively examines the use 
of health care services for children without any congenital anomalies [physician visits 
(F=29.945, p<0.001), hospitalizations (F=31.059, p<0.001) and length of stay 
(F=14.265, p<0.001)].  While the same overall results were seen for children with and 
without congenital anomalies, different patterns of regional differences are revealed by 
the post-hoc tests when the Saskatoon Health Region is used as a reference group (see 
Table 4.10, Figures 4.23-4.25)   
Table 4.10: Crude regional differences in health care utilization for children with and 
without congenital anomalies 
Variable RHAs that are Significantly 
Different from Saskatoon  for 
Children WITH CAs 
(significance level) 
RHAs that are Significantly 
Different from Saskatoon for 
Children WITHOUT CAs 
(significance level) 
 
Sunrise (0.006) 
Heartland (0.009) 
PA Parkland (0.028) 
Northern Saskatchewan (<0.001) 
 
Sun Country (0.047) 
Regina Qu’Appelle (<0.001) 
Heartland (0.011) 
PA Parkland (<0.001) 
Northern Saskatchewan (<0.001) 
 
 
 
Total Number of 
Physician Visits 
See Figure 4.23 
 
 
Five Hills (<0.001) 
Cypress (0.007) 
Regina Qu’Appelle (0.020) 
Sunrise (<0.001) 
Kelsey Trail (0.006) 
PA Parkland (<0.001) 
Prairie North (<0.001) 
Northern Saskatchewan (<0.001) 
 
Sun Country (<0.001) 
Five Hills (<0.001) 
Cypress (<0.001) 
Regina Qu’Appelle (<0.001) 
Sunrise (<0.001) 
Heartland (<0.001) 
PA Parkland (<0.001) 
Prairie North (<0.001) 
Northern Saskatchewan (<0.001) 
 
 
 
Total Number of 
Hospitalizations 
See Figure 4.24 
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PA Parkland (0.006) 
Prairie North (0.001) 
Northern Saskatchewan (<0.001) 
 
Five Hills (0.018) 
Cypress (0.028) 
Regina Qu’Appelle (<0.001) 
Sunrise (<0.001) 
PA Parkland (<0.001) 
Prairie North (<0.001) 
Northern Saskatchewan (<0.001) 
 
 
 
Total Length of Stay 
See Figure 4.25 
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* Significantly different from the Saskatoon Health Region (reference category) for 
children with CAs 
~ Significantly different from the Saskatoon Health Region (reference category) for 
children without CAs 
 
Figure 4.23: Crude regional differences in the mean number of physician visits in the 
first five years of life compared to the Saskatoon Health Region for children with and 
without congenital anomalies 
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* Significantly different from the Saskatoon Health Region (reference category) for 
children with CAs 
~ Significantly different from the Saskatoon Health Region (reference category) for 
children without CAs 
 
Figure 4.24: Crude regional differences in the mean number of hospitalizations in the 
first five years of life compared to the Saskatoon Health Region for children with and 
without congenital anomalies 
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* Significantly different from the Saskatoon Health Region (reference category) for 
children with CAs 
~ Significantly different from the Saskatoon Health Region (reference category) for 
children without CAs 
 
Figure 4.25: Crude regional difference in the mean length of stay (days) in the first five 
years of life compared to the Saskatoon Health Region for children with and without 
congenital anomalies 
 
As can be seen in Table 4.11, with regard to travel to access health care services for 
children with and without congenital anomalies, one way ANOVAs show that at the 5% 
level of significance, for children with congenital anomalies there is a significant 
difference in number of residents ever having to travel outside of their home RHA for a 
physician visit for all regions when the Saskatoon Health Region is used as the reference 
group (F=252.396, p<0.001) (see Table 4.11).  For children without CAs there is a 
significant difference in number of residents ever having to travel outside of their home 
RHA for a physician visit for all regions except for Regina Qu’Appelle when the 
Saskatoon Health Region is used as the reference group (F=152.977, p<0.001).  
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Additionally, as seen in Table 4.11, one way ANOVAs show that at the 5% level of 
significance, there is a difference in number of residents ever having to travel outside of 
their home RHA for a hospital admission for all regions except for Regina Qu’Appelle 
when the Saskatoon Health Region is used as the reference group – this is the same for 
children with and without CAs (children with CAs: F=432.929, p<0.001, children 
without CAs: F=289.237, p<0.001). 
Table 4.11: Crude regional differences in travel for health care utilization for children 
with and without congenital anomalies 
Variable RHAs that are Significantly 
Different from Saskatoon  for 
Children WITH CAs 
(significance level) 
RHAs that are Significantly 
Different from Saskatoon for 
Children WITHOUT CAs 
(significance level) 
 
 
 
Ever Traveled 
Outside of Home 
RHA for a Physician 
Visits 
Sun Country (<0.001) 
Five Hills (<0.001) 
Cypress (<0.001) 
Regina Qu’Appelle (<0.001) 
Sunrise (<0.001) 
Heartland (<0.001) 
Kelsey Trail (<0.001) 
PA Parkland (<0.001) 
Prairie North (<0.001) 
Northern Saskatchewan (<0.001) 
Sun Country (<0.001) 
Five Hills (<0.001) 
Cypress (<0.001) 
Sunrise (<0.001) 
Heartland (<0.001) 
Kelsey Trail (<0.001) 
PA Parkland (<0.001) 
Prairie North (<0.001) 
Northern Saskatchewan (<0.001) 
 
 
 
 
Ever Traveled 
Outside of Home 
RHA for a Hospital 
Admission 
Sun Country (<0.001) 
Five Hills (<0.001) 
Cypress (<0.001) 
Sunrise (<0.001) 
Heartland (<0.001) 
Kelsey Trail (<0.001) 
PA Parkland (<0.001) 
Prairie North (<0.001) 
Northern Saskatchewan (<0.001) 
Sun Country (<0.001) 
Five Hills (<0.001) 
Cypress (<0.001) 
Sunrise (<0.001) 
Heartland (<0.001) 
Kelsey Trail (<0.001) 
PA Parkland (<0.001) 
Prairie North (<0.001) 
Northern Saskatchewan (<0.001) 
4.6 Study Question 3: What Factors Influence the Level of Health Care Utilization? 
As the literature indicates that different factors influence the use of different types of 
health care, separate models were constructed to predict the total number of physician 
visits in the study period, the total number of hospitalizations in the study period and the 
total length of stay (LOS) in hospital during the study period.     
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4.6.1 Model for Number of Physician Visits 
Table 4.12 describes the statistically significant predictors of the total number of 
physician visits for children in Saskatchewan in their first five years of life.   
Table 4.12: Statistically significant predictors of total number of physician visits in the 
first five years of life for children with CAs compared to children without CAs  
Variable Categories Odds 
Ratio 
 
95% 
Confidence 
Interval 
Main Effects 
Need Characteristics 
Congenital 
Anomaly 
No 
Yes
(ref) 
1.19 
(ref) 
1.16-1.21* 
Multiple Congenital 
Anomalies 
No
Yes
(ref) 
1.37 
(ref) 
1.34-1.41* 
Predisposing Characteristics 
Baby's Sex Male 
Female
(ref) 
0.92 
(ref) 
0.90-0.93* 
Registered Indian 
Status 
No
Yes
(ref) 
1.35 
(ref) 
1.31-1.38* 
Parity 1
2
3
4
≥5
(ref) 
0.94 
0.89 
0.84 
0.82 
(ref) 
0.92-0.96* 
0.87-0.91* 
0.81-0.87* 
0.79-0.86* 
Enabling Characteristics 
RHA of Residence 
in Birth Year 
Saskatoon
Sun Country 
Five Hills
Cypress
Regina Qu’Appelle
Sunrise
Heartland
Kelsey Trail
PA Parkland
Prairie North
Northern Saskatchewan
(ref) 
0.63 
0.84 
0.84 
1.01 
0.74 
0.51 
0.69 
0.90 
0.62 
0.23 
(ref) 
0.57-0.69* 
0.79-0.90* 
0.76-0.92* 
0.98-1.04 
0.69-0.80* 
0.43-0.61* 
0.61-0.78* 
0.84-0.96* 
0.57-0.67* 
0.19-0.28* 
Family Ever 
Received Income 
Assistance 
No  
Yes
(ref) 
1.12 
(ref) 
1.10-1.14* 
Child Ever Traveled 
Outside of Home 
RHA for a 
Physician Visit 
 
No
Yes
(ref) 
1.97 
(ref) 
1.65-2.37* 
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Interaction Terms 
RHA x Child Ever 
Traveled Outside of 
Home RHA for a 
Physician Visit 
Saskatoon x Yes Travel
Sun Country x Yes Travel 
Five Hills x Yes Travel
Cypress x Yes Travel
Regina Qu’Appelle x Yes Travel
Sunrise x Yes Travel
Heartland x Yes Travel
Kelsey Trail x Yes Travel
PA Parkland x Yes Travel
Prairie North x Yes Travel
Northern Saskatchewan x Yes Travel
0.60 
0.87 
0.73 
0.70 
0.61 
0.74 
Dropped  
0.82 
0.67 
0.88 
1.49 
0.50-0.72* 
0.71-1.07 
0.60-0.89* 
0.57-0.87* 
0.51-0.73* 
0.60-0.90* 
Dropped~
0.65-1.03 
0.55-0.82* 
0.72-1.08 
1.14-1.94* 
* Statistically Significant 
~ Dropped from the model due to collinearity 
 
As shown in Table 4.12, children who have multiple congenital anomalies visit the 
doctor more often than children who do not have any birth defects (OR=1.19) and 
children who have multiple congenital anomalies visit the doctor more often than other 
children (OR=1.37).  Females have fewer physician visits than males (OR=0.92), while 
children whose families had ever received some form of governmental income 
assistance had more physician visits than children whose families did not receive 
income assistance (OR=1.12).  Furthermore, Registered Indian children visited a 
physician more frequently than the general population of children (OR=1.35).  A dose-
response relationship was observed for parity, with each additional child a mother had 
was associated with decreasing numbers of physician visits for the child. 
 The presence of statistically significant interaction terms between RHA of 
residence and the need to travel outside of one’s home RHA to see a physician implies 
that neither of the terms can be examined in isolation.  This means that when one looks 
at the impact of home RHA on the number of physician visits in the first five years, it 
must be explained in the context of the need to travel outside of one’s home RHA to see 
a physician (i.e. the relationship between home RHA and physician visits is different for 
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children who had to travel outside of their home RHA to see a physician in the first five 
years of life versus children who did not have to travel outside of their home RHA to see 
a physician in the first five years of life).  
4.6.2 Model for Total Number of Hospitalizations 
Table 4.13 shows the variables that are statistically significant predictors of the total 
number of hospitalizations for children in Saskatchewan in the first five years of life.   
Table 4.13: Statistically significant predictors of total number of hospitalizations in the 
first five years of life for children with CAs compared to children without CAs  
Variable Categories Odds Ratio 
 
95% Confidence 
Interval 
Main Effects 
Need Characteristics 
Congenital 
Anomaly 
No 
Yes
(ref) 
1.24 
(ref) 
1.21-1.27* 
Multiple Congenital 
Anomalies 
No
Yes
(ref) 
1.50 
(ref) 
1.45-1.54* 
Birth Weight <1000g
1000g-1499g
1500g-1999g
2000g-2499g
2500g-3999g
≥4000g
(ref) 
0.99 
1.03 
0.94 
0.86 
0.80 
(ref) 
0.86-1.12 
0.91-1.16 
0.84-1.05 
0.78-0.95* 
0.72-0.89* 
Predisposing Characteristics 
Baby's Sex Male 
Female
(ref) 
0.86 
(ref) 
0.85-0.88* 
Registered Indian 
Status 
No
Yes
(ref) 
1.48 
(ref) 
1.43-1.54* 
Mother's Age 
Group 
< 20
20-34
≥35
(ref) 
0.91 
0.86 
(ref) 
0.87-0.94* 
0.82-0.91* 
Mother's Marital 
Status 
Single
Married/Common Law
Other
(ref) 
0.93 
0.99 
(ref) 
0.90-0.96* 
0.94-1.04 
Parity 1
2
3
4
≥5
(ref) 
1.05 
1.06 
1.08 
1.15 
(ref) 
1.02-1.08* 
1.03-1.10* 
1.03-1.13* 
1.09-1.21* 
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Enabling Characteristics 
RHA of Residence 
in Birth Year 
Saskatoon
Sun Country 
Five Hills
Cypress
Regina Qu’Appelle
Sunrise
Heartland
Kelsey Trail
PA Parkland
Prairie North
Northern Saskatchewan
(ref) 
0.97 
1.17 
1.24 
1.17 
1.25 
0.81 
0.95 
0.98 
1.07 
0.78 
(ref) 
0.91-1.02 
1.11-1.23* 
1.16-1.33* 
1.13-1.21* 
1.19-1.32* 
0.76-0.87* 
0.89-1.02 
0.93-1.03 
1.02-1.12* 
0.74-0.83* 
Family Ever 
Received Income 
Assistance 
No  
Yes
(ref) 
1.12 
(ref) 
1.09-1.15* 
Child Ever Traveled 
Outside of Home 
RHA for a 
Hospitalization 
No
Yes
(ref) 
1.75 
(ref) 
1.70-1.80* 
Child Moved to 
Another RHA 
No
Yes
(ref) 
0.95 
(ref) 
0.91-0.99* 
* Statistically Significant 
 
As can be seen in Table 4.13, the adjusted odds ratio for RHA is statistically significant 
for seven of the ten regions included, meaning that children who lived in Heartland 
(OR=0.81) and Northern Saskatchewan (OR=0.78) at the end of their first year of life 
are hospitalized less often in the first five years than children in Saskatoon (the reference 
category), and children in Five Hills (OR=1.17), Cypress (OR=1.24), Regina 
Qu’Appelle (OR=1.17) and Sunrise (OR=1.25) at the end of their first year of life are 
hospitalized more often in the first five years than children in Saskatoon (the reference 
category).  Not surprisingly, children with at least one congenital anomaly were more 
likely to be hospitalized than children without congenital anomalies (OR=1.24) and 
children with multiple congenital anomalies were also more likely to be hospitalized 
than other children (OR=1.50).  Females were less likely than males to be hospitalized 
(OR=0.86), and Registered Indian children were more likely than the general population 
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of children to be hospitalized (OR=1.48).  Children who had moved to another RHA 
during the study period were less likely to be hospitalized than children who did not 
move to another RHA (OR=0.95), and children who had to travel outside of their home 
RHA for a hospitalization were more likely to be hospitalized than children who did not 
have to travel outside of their home RHA for a hospitalization (OR=1.75).  With regards 
to maternal factors that were predictive of a child’s number of hospitalizations, being in 
married or in a common law relationship at the time of the child’s birth is associated 
with fewer hospitalizations, compared to being single (OR=0.93).  Additionally, 
children whose mothers were between the ages of 20 and 34 (OR=0.91) and 35 years or 
older (OR=0.86) at the time of their child’s birth were less likely to be hospitalized than 
children whose mothers were teenagers when they were born.  A dose-response 
relationship was observed for parity, with each additional child a mother had increasing 
the number of hospitalizations for the child included in this study as compared to first 
time mothers. 
4.6.3 Model for Total Length of Stay 
Table 4.14 shows the variables that are statistically significant predictors of the total 
length of stay in hospital for children in Saskatchewan in the first five years of life.   
Table 4.14: Statistically significant predictors of total length of stay in hospital in the 
first five years of life for children with CAs compared to children without CAs  
Variable Categories Odds Ratio 
 
95% Confidence 
Interval 
Main Effects 
Need Characteristics 
Congenital Anomaly No 
Yes
(ref) 
1.26 
(ref) 
1.22-1.29* 
Multiple Congenital 
Anomalies 
No
Yes
(ref) 
2.09 
(ref) 
2.01-2.17* 
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Birth Weight <1000g
1000g-1499g
1500g-1999g
2000g-2499g
2500g-3999g
≥4000g
(ref) 
0.94 
0.54 
0.32 
0.21 
0.20 
(ref) 
0.77-1.14 
0.43-0.66* 
0.26-0.39* 
0.17-0.26* 
0.16-0.24* 
Gestational Age < 28 weeks
28-36 weeks
37-41 weeks
≥42 weeks
(ref) 
0.92 
0.55 
0.54 
(ref) 
0.76-1.12 
0.45-0.67* 
0.44-0.67* 
Predisposing Characteristics 
Baby's Sex Male 
Female
(ref) 
0.88 
(ref) 
0.86-0.91* 
Registered Indian 
Status 
No
Yes
(ref) 
1.79 
(ref) 
1.70-1.89* 
Mother's Age Group < 20
20-34
≥35
(ref) 
0.88 
0.86 
(ref) 
0.84-0.91* 
0.81-0.92* 
Parity 1
2
3
4
≥5
(ref) 
0.94 
0.96 
1.01 
1.21 
(ref) 
0.91-0.97* 
0.93-1.00 
0.96-1.06 
1.14-1.28* 
Enabling Characteristics 
RHA of Residence in 
Birth Year 
Saskatoon
Sun Country 
Five Hills
Cypress
Regina Qu’Appelle
Sunrise
Heartland
Kelsey Trail
PA Parkland
Prairie North
Northern Saskatchewan
(ref) 
0.99 
1.15 
1.24 
1.13 
1.28 
0.99 
0.94 
0.92 
0.98 
0.86 
(ref) 
0.91-1.08 
1.07-1.24* 
1.12-1.37* 
1.09-1.17* 
1.19-1.38* 
0.86-1.14 
0.85-1.04 
0.86-0.98* 
0.92-1.06 
0.74-1.01 
Family Ever 
Received Income 
Assistance 
No  
Yes
(ref) 
1.21 
(ref) 
1.18-1.25* 
Child Ever Traveled 
Outside of Home 
RHA for 
Hospitalization 
No
Yes
(ref) 
1.58 
(ref) 
1.35-1.86* 
Child Moved to 
Another RHA 
No
Yes
(ref) 
0.88 
(ref) 
0.83-0.92* 
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Interaction Terms 
RHA x Child Ever 
Traveled Outside of 
Home RHA for a 
Hospital Admission 
Saskatoon x Yes Travel
Sun Country x Yes Travel 
Five Hills x Yes Travel
Cypress x Yes Travel
Regina Qu’Appelle x Yes Travel
Sunrise x Yes Travel
Heartland x Yes Travel
Kelsey Trail x Yes Travel
PA Parkland x Yes Travel
Prairie North x Yes Travel
Northern Saskatchewan x Yes Travel
1.40 
0.97 
1.05 
1.09 
1.31 
1.09 
0.78 
1.14 
1.28 
1.30 
dropped 
1.17-1.68* 
0.79-1.18 
0.86-1.28 
0.87-1.37 
1.10-1.57* 
0.90-1.33 
0.63-0.98* 
0.92-1.41 
1.06-1.54* 
1.08-1.56* 
Dropped~
Congenital Anomaly 
x Registered Indian 
CA Yes x RI Yes 1.14 1.07-1.22* 
* Statistically Significant 
~ Dropped from the model due to collinearity 
 
As illustrated in Table 4.14, again, children with multiple congenital anomalies 
(OR=2.09) spend more days in a hospital than other children and females have a shorter 
length of stay than males (OR=0.88).  An inverse dose response relationship was 
observed between birth weight and length of stay; as birth weight increases, length of 
stay decreases; however, this relationship did not achieve statistical significance for 
babies who weighed between 1000g and 1499g at birth.  Term and post-term infants 
have a shorter length of stay than very preterm infants (OR=0.55 and OR=0.54 
respectively); however, there is no difference in length of stay for preterm and very 
preterm infants.  A child moving to another RHA was protective in terms of length of 
stay (OR=0.88).  Children whose mothers were between the ages of 20 and 34 at the 
time of their birth had a shorter length of stay than children who were born to teen 
mothers (OR=0.88), and children whose mothers were over 35 at the time of their birth 
also had a shorter LOS compared to children who were born to teen moms (OR=0.86).  
An overall dose-response relationship was observed between children’s length of stay 
and mother’s parity; however, only categories parity=2 (OR=0.94) and parity=5 or more 
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(OR=1.21) achieved statistical significance.  Finally, children whose families ever 
received some sort of government income assistance had a longer length of stay in 
hospital than children whose families did not receive any income assistance (OR=1.21). 
The presence of statistically significant interaction terms between RHA and the 
need to travel outside of one’s home RHA for a hospital admission implies that neither 
of the terms can be examined in isolation.  This means that when one looks at the impact 
of home RHA on the total length of stay in the first five years, it must be explained in 
the context of the need to travel outside of one’s home RHA for a hospitalization (i.e. 
the relationship between home RHA and length of stay is different for children who had 
to travel outside of their home RHA to be hospitalized in the first five years of life 
versus children who did not have to travel outside of their home RHA to be hospitalized 
in the first five years of life).  The same can also been said for the Registered Indian 
children with and without congenital anomalies – the relationship between Registered 
Indian status and length of stay is different for children with and without CAs. 
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CHAPTER FIVE: DISCUSSION AND CONCLUSIONS 
 
This chapter begins by interpreting the results of the present study and discussing the 
practical implications of these results.  This is followed by descriptions of the study 
strengths and limitations, and finally a discussion of future research that could be 
undertaken in this area. 
5.1 Interpretation of Results 
It was hypothesized that children with CAs would have a higher level of health care 
utilization than children without CAs in their first five years of life; and that this 
relationship would be significantly affected by a variety of factors related to need, 
predisposing characteristics and enabling characteristics of the children and necessarily 
of their caregivers.  Furthermore, it was also hypothesized that a regional disparity in the 
level of health service utilization would be found. 
 Not surprisingly, the results indicate that with the exception of children who 
have CAs of the integument (ICD-9 757), children with congenital anomalies have a 
higher level of health care utilization than children without congenital anomalies.  While 
CAs of the integument (i.e. the skin) can sometimes be serious it is unlikely that a CA in 
this category would constitute a major disability or require a great deal of close 
monitoring by a physician.  
When one examines the predictive models for each type of health care utilization 
studied, one does indeed find that factors related to need (e.g. CA status, gestational age, 
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birth weight), as well as predisposing characteristics (e.g. sex, mother’s age group, 
Registered Indian status, etc) and enabling characteristics (e.g. home RHA, travel 
outside of home RHA for services, etc) influence a child’s use of health care services 
throughout their first five years of life. 
 While regional differences were found in the use of health care services for 
children with and without congenital anomalies, a regional difference in the overall 
prevalence of congenital anomalies was not found.  Additionally, due to concerns 
regarding sample size it was not possible to do a regional comparison of use of health 
care services for children with specific congenital anomalies.  The combination of these 
factors makes it impossible to assess the accuracy of the second hypothesis in this study. 
5.1.1 Regional Differences in the Prevalence of Congenital Anomalies 
Regional differences were seen in the prevalence of most specific congenital anomalies.  
This could be due to a variety of factors, such as: 
• Differences due to maternal risk factors (e.g. rates of smoking during pregnancy, 
proportion of women taking preconceptional folic acid, maternal age) (6, 63). 
• Differences in environmental exposures (6, 7, 63). 
• Differences in the ethnic make-up of the health regions (i.e. Aboriginal people 
make up a larger percentage of the total population in Northern Saskatchewan 
than they do in the rest of the province) (7, 63). 
• Differences in access to care and prenatal diagnostic services (63). 
• Variation due to chance (63).   
It is unlikely that all of the regional differences seen in the prevalence of CAs can be 
attributed to chance due to the large number of differences seen. 
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5.1.2 Study Question 1: Is the Level of Health Care Used by Children With 
Congenital Anomalies Significantly Different from the Level of Health Care Used 
by Children Without Congenital Anomalies?   
When examining the broad groupings of children who have at least one congenital 
anomaly compared to children who do not have any congenital anomalies, children with 
CAs had a higher level of health care use for all three outcome variables.  This is 
expected as need for care is the greatest predictor of use of health care services and 
children with CAs have a greater need for care than children without CAs (11).   
 This question was further broken down to determine if children with specific 
types of congenital anomalies had a higher level of health care utilization than children 
without that particular CA.  With few exceptions, children with specific types of CAs 
also had a higher level of health care use.  The one notable exception is for children 
affected by CAs of the integument (ICD-9 757) for whom there was no significant 
difference between them and children without CAs of the integument for all outcome 
variables.  This is likely due to the fact that CAs of the integument (i.e. the skin) while 
sometimes serious in nature tend to not be life-threatening or cause major disabilities. 
5.1.3 Study Question 2: Is There a Regional Difference in the Level of Health Care 
Used by Children in their First Five Years of Life?  And Does This Relationship 
Hold For Children With and Without CAs? 
Statistically significant regional differences were found for the three health care use 
outcome variables in this study population.  Regional differences were found for all 
three outcome variables for children with and without CAs, but different patterns were 
seen based on CA status.  More regional differences for all outcome variables were seen 
for children without CAs than for children with CAs.  This may indicate that while 
children with the greatest need (i.e. those with CAs) are able to access appropriate care, 
those without CAs may have more difficulty accessing care. 
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 The greatest differences in level of care between children with and without 
congenital anomalies is for length of stay.  For children with CAs, on average, those in 
the northern parts of the province (Northern RHAs, Prairie North Regional Health 
Authority and PA Parkland Regional Health Authority) have statistically significant 
longer lengths of stay compared to those in the Saskatoon Health Region.  Length of 
stay is also higher in the Kelsey Trail Regional Health Authority although this did not 
reach statistical significance.  There are a few potential explanations for this such as 
differential access to outpatient services throughout the province, different hospital 
policies on length of stay and the severity and complexity of the condition for which 
care is sought.  This study is not able to conclusively determine which explanation or 
which combination of explanations clarifies this difference.  Individuals in these regions 
may have longer lengths of stay as they do not have as ready access to out-patient care 
in their region, these children may be sicker and require more time in hospital, and/or 
there might be different hospital policies on length of stay in these regions than their 
southern counterparts.  As this same pattern is not seen for children without congenital 
anomalies, this difference is not likely due to hospital policies.  While less access to 
outpatient care may necessitate the longer length of stay that is seen for children in the 
far north, the same cannot be said for children in the Prince Albert Parkland Regional 
Health Authority as there are a number of pediatricians practicing in Prince Albert.   
As travel variables had been derived for use in the predictive models, this study 
was also able to examine regional differences in the need to travel outside of one’s home 
RHA for hospital admissions or physician visits.  With the exception of residents of the 
Regina Qu’Appelle health region for some of the specific CAs investigated, residents of 
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all other regions were significantly more likely to travel outside of their home RHA for 
physician visits and hospitalizations compared to children in the Saskatoon Health 
Region.  The need to travel outside of one’s home RHA for health care was significantly 
higher for children of almost all RHAs compared to children in the Saskatoon Health 
Region.  This should not indicate a degree of acceptance of the current need to travel to 
obtain care by policy makers and the public.  Health care and support services that are 
easily accessible allow people with disabilities to lead more independent and healthier 
lifestyles, and as this population of children grows up to be a population of adults with 
disabilities access becomes increasingly important (4). 
 The crude regional differences in use of health care services indicates that even 
with universal access to essential services in Saskatchewan, both regional differences in 
policies and availability of services may influence one’s use of services (8).  
Furthermore, CA status may not be a predictor of differential use of health care services 
for regional health authorities in Saskatchewan.  When the same regional difference is 
found for both children with and without CAs (i.e. as is seen for Northern Saskatchewan 
in Table 4.10 for all outcome variables) for a health outcome, this indicates that the 
reason for this difference is not related to CA status, but instead to a different factor that 
was not measured by this particular study. 
5.1.4 Study Question 3: What Factors Influence the Level of Health Care 
Utilization? 
As can be seen in Table 5.1, while many of the same variables predict different 
outcomes related to health care utilization, the predictive model for each outcome is 
different. 
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Table 5.1: Statistically significant variables in models for level of health care utilization 
Variable Model for 
Physician 
Visits 
Model for 
Hospital 
Admissions 
Model for 
Length of 
Stay 
Main Effects 
Need Characteristics 
Congenital Anomaly X X X 
Multiple Congenital Anomalies X X X 
Birth Weight  X X 
Gestational Age   X 
Predisposing Characteristics 
Baby's Sex X X X 
Registered Indian Status X X X 
Mother's Age Group  X X 
Mother's Marital Status  X  
Parity X X X 
Enabling Characteristics 
RHA of Residence in Birth Year X X X 
Family Ever Received Income Assistance X X X 
Child Ever Traveled Outside of Home RHA for 
Hospitalization or Physician Visit 
X X X 
Child Moved to Another RHA  X X 
Interaction Terms 
Home RHA x Child Ever Traveled Outside of 
Home RHA for a Hospitalization or Physician 
Visit  
X  X 
 
Congenital Anomaly x Registered Indian   X 
 
According to Anderson and Newman’s model of the individual determinants of health 
services utilization, three general categories of variables work together to determine 
what level of health care an individual will use: need characteristics (i.e. factors related 
to how ill one is), predisposing characteristics (i.e. intrinsic factors that make some 
individuals more likely than others to seek out treatment) and enabling characteristics 
(i.e. factors in one’s environment that allow them to access services) (11, 41).  All 
variables tested in the models for health care utilization were grouped according to these 
characteristics.  As expected, congenital anomaly status and multiple congenital 
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anomaly status were significant in all three models.  In addition, baby’s sex, Registered 
Indian status, RHA of residence, receipt of income assistance and the need to travel 
outside of one’s home RHA to access services were statistically significant in all three 
models.   
As need for care is the most pressing determinant of use of health care services, 
it is not surprising to see that children with birth defects have more physician visits, 
more hospitalizations and longer lengths of stay than children without CAs.  Research 
has shown that children with CAs require more and longer hospitalizations than children 
without CAs (66).  Furthermore, as expected both gestational age and birth weight 
achieved statistical significance in the model for length of stay.  The last few weeks of 
pregnancy are essential for the healthy development of children, and babies that are born 
too soon are at a higher risk of developing health problems immediately after birth (i.e. 
respiratory distress syndrome, intraventricular hemorrhage) and later in life (i.e. cerebral 
palsy) (67).  The birth weight variable achieved statistical significance in the model for 
number of hospitalizations.  This indicates that not only are low-birth weight babies 
more likely to stay in the hospital longer, they are also more likely to be re-hospitalized 
throughout their first five years of life compared to their normal birth weight peers.  The 
same pattern was not seen for gestational age.   
Infants are admitted to the hospital for a variety of reasons.  Research conducted 
in Saskatchewan found that the leading causes of hospitalization for children in the first 
28 days of life between 1989 and 1994 are: perinatal conditions (88%) [this includes 
jaundice (38%), asphyxia and hypoxia (20%), prematurity and low birth weight (16%)] 
and congenital anomalies (7%) (66).  The leading causes of congenital anomaly related 
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hospitalizations for children under 10 were for CAs of the musculoskeletal system 
(25%), the heart and circulatory system (20%) and the digestive system (12%) (66).   
While the overall health of the child is the greatest predictor in postnatal hospital 
readmissions, other factors seen in the literature that impact readmission are: mother’s 
concerns regarding infant care, the amount of help a new mother receives at home 
following her initial discharge and whether the baby was seen by a health professional 
for a physical check-up after the initial hospital discharge (67).  To the extent that this 
study was able to measure these characteristics, the findings are consistent with the 
literature as regions that had high number of physician visits for the most part also had 
low numbers of hospital admissions 
In all three models, female children used less health care services than male 
children.  This contradicts the general trends in the literature which show that females 
exhibit more health seeking behaviours than males and consequently use more health 
services (68).  However, the literature has tended to focus on adult men and women who 
can choose to access or not access care, male and female children do not have that same 
level of autonomy.  It is possible that this difference reflects a greater need for care for 
male children than female children in the study population. 
Registered Indian children have more physician visits, more hospitalizations and 
longer lengths of stay than the general population of children in the study.  This could 
also be a reflection of an increased need for services, since as a group, individuals with 
Registered Indian status suffer from poorer health than individuals in the general 
population (33). 
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Mother’s age group reached statistical significance in the models for 
hospitalizations and length of stay and in both cases not being a teen mother was 
protective.  This is consistent with other findings.  The ability of parents to manage their 
child’s care outside of a hospital setting and their ability to recognize when care is 
needed influences the number of hospitalizations for their children and the amount of 
time their children are required to spend in the hospital (46).  This finding could also be 
due to the fact that teen mothers are more likely to have low birth weight babies than 
older mothers.  Low birth weight babies require more hospitalizations and on average 
have longer lengths of stay (46).  Similarly, a child moving to another RHA during the 
study period was protective in the models for hospital admissions and length of stay.  
This is most likely because parents tended to move their children to larger urban centres 
where more specialized care was available on an out-patient basis, thus reducing the 
need for hospitalizations and time in hospital. 
Mother’s marital status only attained statistical significance in the model for the 
total number of hospitalizations.  While results are expected (children whose mothers 
were married or in a common law relationship had fewer hospitalizations than children 
born to single mothers), it is surprising that this variable did not reach significance in the 
other models, especially the model for the total number of physician visits.  Mother’s 
marital status acts as a proxy for social support which should, in theory, increase a 
mother’s ability to obtain care for her child, and as she seeks out more physician visits 
for her child, her child would, in turn, require fewer hospitalizations. 
Somewhat surprisingly, parity was the only maternal variable to achieve 
statistical significance in all three models; however, not unexpectedly, while a dose-
 92
response relationship was observed in all models, an inverse relationship was seen for 
physician visits and hospitalizations/length of stay.  As the number of children a woman 
has increases, the number of physician visits per child decreases.  This could be 
reflective of the increasing demands on her time brought about by having additional 
children to care for and a lack of social support.  As the number of children a woman 
has increases, the number of hospitalizations per child and the length of stay per 
hospitalization increases.  Both of these factors go hand-in-hand with the pattern seen 
for the relationship between maternal parity and number of physician visits for her 
children.  As women have more children they may have less time on their hands to focus 
on preventative care, consequently, these children require more hospitalizations (it is 
unknown whether the rate of ambulatory case sensitive [ACS] conditions also increase 
with maternal parity). 
 Children whose families ever received some sort of governmental income 
assistance during the study period had higher numbers of physician visits, 
hospitalizations and longer lengths of stay.  This is consistent with other studies as the 
literature indicates that children who live in low-income families tend to experience 
more chronic health problems and developmental disabilities (66).  This results in a 
greater need for health care services than is experienced by children from higher income 
families. 
 Of the six interaction terms tested in the models, only two achieved statistical 
significance in any of the models.  No interaction terms were significant in the model 
for hospitalizations.  Children’s health region of residence and traveling outside of the 
region showed a significant interaction for the outcomes related to length of stay and 
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total number of physician visits.  Children’s congenital anomaly status and Registered 
Indian status also showed a significant interaction for the length of stay outcome 
variable.  By examining the interaction between a child’s home RHA and the need for a 
child to travel outside of one’s home RHA for a physician visit in the model for 
physician visits, one can see that, with the exception of children in Northern 
Saskatchewan, children who have to travel outside of their home RHA to see a 
physician, have fewer physician visits than children who do not have to travel outside of 
their home RHA.  A different pattern is seen when examining this interaction term in the 
length of stay model.  Children who live in the Saskatoon Health Region, the Regina 
Qu’Appelle Health Region, the Prince Albert Parkland Health Region and the Prairie 
North Health Region and need to travel outside of their home RHA for a hospital 
admission, have longer lengths of stay than children who live in these same health 
regions who do not need to travel.  This is could be an indication of need.  The opposite 
pattern is seen for children who live in the Heartland Health Region – children who live 
in the Heartland Health Region and need to travel outside of their home RHA for a 
hospitalization have shorter lengths of stay than children who do not have to travel 
outside of the Heartland Health Region for a hospitalization.  This could reflect different 
regional policies surrounding length of stay.  Larger regions that can offer more 
specialized care could be more likely to have stricter policies on length of stay as they 
have a greater need for beds, and children in these regions have easier access to follow-
up care on an outpatient basis. 
 The interaction term between congenital anomaly status and Registered Indian 
status acts synergistically in the length of stay model indicating that the relationship 
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between Registered Indian status and length of stay is different for children with and 
without CAs.  Children with Registered Indian status and congenital anomalies had 
longer lengths of stay than children with congenital anomalies but without Registered 
Indian status.  This is expected as the same pattern is seen for the constituent parts of 
this interaction term in all three models (i.e. Registered Indian status children use 
significantly more health care than the general population of children and children with 
CAs use significantly more health care than children without CAs). 
 What’s particularly important about examining the models that predict a child’s 
use of various health care services in the first five years of life; is that after adjustment 
for need characteristics, predisposing factors and enabling factors, a different pattern of 
regional differences emerges than in the previous question when one was merely 
examining crude differences.  These adjusted differences are far more meaningful as 
they eliminate many differences between regions that could account for the differential 
use of health care. 
5.2 Practical Implications of Results and Directions for Future Research 
In order to prevent CAs, it is first essential to know what the baseline measures are for 
the prevalence of specific CAs in a population and the dispersion of CAs within that 
population (7, 69).  Once baseline measures have been established prevention programs 
can be developed for both the principal condition as well as any associated co-
morbidities that can reduce the quality of life for affected individuals (69).  This is the 
first study of its kind in Saskatchewan to examine the regional differences in rates of all 
categories of CAs.  This study found that regional differences do exist in rates of certain 
types of CAs.  These differences in and of themselves require additional studies with a 
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finer level of detail for the definition of these types of CAs to determine exactly what 
regional differences exist. Furthermore, future studies need information on rates of 
prenatal testing for certain conditions to determine whether we are seeing a true regional 
difference in rates of CAs or merely a regional difference in the live birth rate for CAs.  
These studies also require information on whether or not these conditions are genetically 
induced or environmentally induced to determine if these regional differences could 
potentially be prevented.  While more information is necessary to fully assess the extent 
of these regional differences, the prevalence estimates from the current study are 
important to plan for both the special educational and the health care needs of this 
population (63).  To continually assess the regional differences in rates of CAs, there is 
a need for the routine monitoring of CAs, such as seen in other provinces with 
congenital anomalies registries, to track regional disparities over time and monitor 
trends in real time.   
 Regional differences were also found to exist for all outcome variables related to 
the use of health care services and in travel for health care services.  These regional 
differences need to be further examined by Saskatchewan Health as it may indicate that 
residents are receiving different levels of care based on where they live in the province.  
Future studies are needed to also look at regional differences in access to care within 
health regions.  As hospital care is more costly than ambulatory care, regional 
differences in hospitalizations should be closely examined to see why regional 
differences exist and what can be done about them (i.e. increased numbers of nurse 
practitioners and physicians in rural/remote areas, increased focus on the prevention of 
disease, etc). 
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 While this study was able to determine that regional differences do in fact exist 
for rates of congenital anomalies and use of health care services, it was not able to 
answer the more meaningful questions “Are these differences also inequities?” and “Are 
the differences seen as unfair?”  Future studies that involve both quantitative and 
qualitative methodologies will be required to provide a clear answer to this question.  
5.3 Study Strengths 
While this study has shortcomings, there are strengths associated with the study design 
and methodology.  Foremost, this is a longitudinal cohort study, which is one of the 
most robust epidemiological study designs.  As cohort studies begin with an exposed 
and unexposed group and follow the groups over time to assess an independent outcome 
variable, cohort designs are free from many biases that can plague case-control and 
cross-sectional studies.  The second major strength to this study is its large sample size 
which increases the likelihood that the sample population will be representative of the 
general population.   
 An additional strength of this study is the five year ascertainment period for 
congenital anomalies.  While all congenital anomalies are present at birth, many of them 
are not diagnosed until much later (1, 2, 12, 13).  The longer ascertainment period is 
especially important for this particular study as the diagnosis of a CA at any point in 
time could result in a higher level of health care services around the time of diagnosis.  
If this had not been accounted for it could have resulted in an overestimate of the level 
of health care services for children ‘without’ CAs.  Along this same line, using separate 
outcome variables (physician visits, hospital admissions and length of stay) is a study 
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strength, as it provides a more complete picture of the factors that predict the use of 
multiple health care services. 
Finally, using administrative data strengthens this study because this data was 
not collected with a specific hypothesis in mind, it is free of certain types of bias that are 
common in studies that rely on survey data such as recall bias and selection bias. 
5.4 Study Limitations 
This study has certain limitations, and the results of the study must be interpreted with 
these in mind.  The administrative categorization of congenital anomaly status was large 
and encompassed a wide range of conditions and therefore it was not possible to 
determine the possible causes of specific conditions.  Also, it was not possible to 
ascertain the severity of a specific anomaly, which limits the practicality of this study in 
health care planning (63).  It is unknown in what direction this may bias the results.  
While the adaptation of the ICD-10 system will partially address the issue related to the 
categorization of CAs in future studies, it was not possible to use ICD-10 coding for this 
study as the coding changed part-way through the study period.  It was not possible to 
reclassify the ICD-9 codes into ICD-10 codes based on the available data.  Additionally, 
it is not known who made the diagnosis of a CA (i.e. a family physician versus a 
specialist).  This may have caused some normal variations to be classified as CAs which 
would bias the results towards the null if ‘healthy’ people were erroneously classified as 
‘diseased’. 
 In addition to the definition of CA status, there are also limitations associated 
with only using Registered Indian status to differentiate between those of Aboriginal 
ancestry and those who do not self-identify as Aboriginal.  The term Aboriginal is an 
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umbrella term that includes all people of Aboriginal origin (First Nations, Métis and 
Inuit) (33).  Within this group, people of First Nations or Inuit ancestry may or may not 
be registered under the Indian Act (there is not a similar piece of registration for the 
Métis) (33).  The Indian Registry is a national database of all Registered First Nations 
who are eligible to receive benefits from the First Nations and Inuit Health Branch 
(FNIHB)’s Non-Insured Services (32).  As not all people who self-declare as Aboriginal 
are registered under the Indian Act (and Métis people cannot be registered under this 
act), any definition of ‘Aboriginal’ that is limited to Registered Indians is an 
underestimate.  A study conducted in Manitoba attempted to more completely ascertain 
the number of First Nations people living in Manitoba than was identified in the 
Manitoba Health Registry alone (a database that includes all Manitoba residents who 
receive universal health insurance) (32).  After combining data from the Medical 
Services Branch of FNIHB, from Manitoba Health and from the Manitoba Health 
Registry (as maintained by the Manitoba Centre for Health Policy), they found that 
while there was an increase in every age group, most groups gained approximately 25% 
more individuals (32).  Additionally, while the researchers did not feel that there was a 
geographic pattern to these increases, the largest geographical increase was in 
Registered First Nations people living off reserve (32).  While it is not known if similar 
increases would be seen with a comparison of data from Saskatchewan Health and 
FNIHB, it is probable.  As this study was only using Registered Indian status as a 
measure of Aboriginals in Saskatchewan, it is likely that this underestimates the 
difference between Aboriginals and non-Aboriginals for all outcome variables. 
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 Another limitation associated with the use of administrative data in this 
particular study, is only obtaining information on physician visits from the medical 
services database, as this does not capture all ambulatory care visits.  The information in 
this database is based on fee-for-service physicians’ payment claims (61).  While 
physicians under an alternative payment plan have the option of shadow billing, this is 
not mandatory; additionally, ambulatory care provided by nurse practitioners is not 
captured in this database.  This will result in an underestimate in the number of 
physician visits throughout the province, but this underestimate will be greatest in the 
north where there are fewer physicians, and the majority of the day-to-day care is 
provided by nurses.  Moreover, there is also no information on the type of physician (i.e. 
specialists versus general practitioner) that a child saw, which could influence the 
number of visits required or on the length of stay policies in the various hospitals.  This 
could also influence the amount of time children spent in the hospital based on where 
they lived. 
 Another limitation associated with using administrative data is that it does not 
allow researchers to account for some potential confounders such as maternal education 
level, etiology of the congenital anomaly (i.e. genetically induced versus 
environmentally induced), use of non-traditional health care services, etc – all of which 
might have influenced the outcome variables.  
Another limitation of this study is the use of a static reference group.  While 
selecting the Saskatoon Health Region as the reference group eased the data analysis 
and interpretation, the use of one reference group does not provide a true picture of all 
the regional differences in the prevalence of congenital anomalies or the level of health 
 100
care utilization.  When calculating the prevalence of congenital anomalies, it is possible 
that these rates are affected by an ascertainment bias as some conditions may be more or 
less likely to be diagnosed prenatally in certain regions than others, and this could have 
influenced the live birth rate.  Also, due to small sample sizes, it was not possible to do 
region specific and congenital anomaly specific analyses. 
5.5 Conclusions 
While a number of variables (both outcome and predictor) were examined in the course 
of this study, this study is really only one of many that can, and should, be done in this 
area.  This study was able to describe what is currently happening, but it was not able to 
explain why things were currently happening, or what could be done to change the 
current situation.  
 This study was able to conclusively show that as expected children with CAs use 
a higher level of health care services (physician visits, hospitalizations and length of 
stay) than children without CAs in the first five years of life; and that regional 
differences are present for the total population and for children with and without CAs.  
When examining the factors that predict a child’s use of health care services, region of 
residence remained a significant predictor of all outcome variables even after adjusting 
for a variety of factors related to a child’s need for health care, and the factors that 
predispose and enable a child and his or her mother to access care.  This significant 
finding indicates that there is a need for further studies in this area and closer real-time 
monitoring of children with CAs in Saskatchewan to ensure that this vulnerable 
population is receiving the best (and most timely and accessible) care possible. 
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APPENDIX A: ICD-9 AND ICD-10 CODES FOR CONGENITAL ANOMALIES 
 
A description of all the ICD-9 codes for congenital anomalies found in the study 
population can be found in Table A-1.  Due to small sample sizes, the children with 
either ICD-9 740 and/or ICD-9 741 were grouped together into the new category ICD-9 
740+741.  Also due to small sample sizes, all ICD10 codes found in the study 
population were recoded to ICD-9 codes, please see Table A-2 for a description of how 
ICD10 codes were reclassified. 
 
Table A.1: ICD-9 and MSB codes for congenital anomalies found in the study 
population 
ICD-9 
Codes 
Description 
740 + 741 Neural Tube Defects 
Includes: 
740 Anencephalus and similar anomalies 
740.0  Anencephalus 
740.1 Craniorachischisis 
740.2 Iniencephaly 
741 Spina bifida 
741.0 With hydrocephalus 
741.9 Without mention of hydrocephalus 
742 Other congenital anomalies of nervous system 
Includes:  
742.0 Encephalocele 
742.1 Microcephalus 
742.2 Reduction deformities of brain 
742.3 Congenital hydrocephalus 
742.4 Other specified anomalies of brain 
742.5 Other specified anomalies of spinal cord 
742.8 Other specified anomalies of nervous system 
742.9 Unspecified anomaly of brain, spinal cord, and nervous system 
743 Congenital anomalies of eye 
Includes: 
743.0 Anophthalmos 
743.1 Microphthalmos 
743.2 Buphthalmos 
743.3 Congenital cataract and lens anomalies 
743.4 Coloboma and other anomalies of anterior segment 
743.5 Congenital anomalies of posterior segment 
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743.6 Congenital anomalies of eyelids, lacrimal system, and orbit 
743.8 Other specified anomalies of eye 
743.9 Unspecified anomaly of eye 
744 Congenital anomalies of ear, face, and neck 
Includes: 
744.0 Anomalies of ear causing impairment of hearing 
744.1 Accessory auricle 
744.2 Other specified anomalies of ear 
744.3 Unspecified anomaly of ear 
744.4 Branchial cleft cyst or fistula; preauricular sinus 
744.5 Webbing of neck 
744.8 Other specified anomalies of face and neck 
744.9 Unspecified anomalies of face and neck 
745 Bulbus cordis anomalies and anomalies of cardiac septal closure 
Includes: 
745.0 Common truncus 
745.1 Transposition of great vessels 
745.2 Tetralogy of Fallot 
745.3 Common ventricle 
745.4 Ventricular septal defect 
745.5 Ostium secundum type atrial septal defect 
745.6 Endocardial cushion defects 
745.7 Cor biloculare 
745.8 Other 
745.9 Unspecified defect of septal closure 
746 Other congenital anomalies of heart 
Includes: 
746.0 Anomalies of pulmonary valve 
746.1 Tricuspid atresia and stenosis, congenital 
746.2 Ebstein's anomaly 
746.3 Congenital stenosis of aortic valve 
746.4 Congenital insufficiency of aortic valve 
746.5 Congenital mitral stenosis 
746.6 Congenital mitral insufficiency 
746.7 Hypoplastic left heart syndrome 
746.8 Other specified anomalies of heart 
746.9 Unspecified anomaly of heart 
747 Other congenital anomalies of circulatory system 
Includes: 
747.0 Patent ductus arteriosus 
747.1 Coarctation of aorta 
747.2 Other anomalies of aorta 
747.3 Anomalies of pulmonary artery 
747.4 Anomalies of great veins 
747.5 Absence or hypoplasia of umbilical artery 
747.6 Other anomalies of peripheral vascular system 
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747.8 Other specified anomalies of circulatory system 
748 Congenital anomalies of respiratory system 
Includes: 
748.0 Choanal atresia 
748.1 Other anomalies of nose 
748.2 Web of larynx 
748.3 Other anomalies of larynx, trachea, and bronchus 
748.4 Congenital cystic lung 
748.5 Agenesis, hypoplasia, and dysplasia of lung 
748.6 Other anomalies of lung 
748.8 Other specified anomalies of respiratory system 
748.9 Unspecified anomaly of respiratory system 
749 Cleft palate and cleft lip 
Includes: 
749.0 Cleft palate 
749.1 Cleft lip 
749.2 Cleft palate with cleft lip 
750 Other congenital anomalies of upper alimentary tract 
Includes: 
750.0 Tongue tie 
750.1 Other anomalies of tongue 
750.2 Other specified anomalies of mouth and pharynx 
750.3 Tracheoesophageal fistula, esophageal atresia and stenosis 
750.4 Other specified anomalies of esophagus 
750.5 Congenital hypertrophic pyloric stenosis 
750.6 Congenital hiatus hernia 
750.7 Other specified anomalies of stomach 
750.8 Other specified anomalies of upper alimentary tract 
750.9 Unspecified anomaly of upper alimentary tract 
751 Other congenital anomalies of digestive system 
Includes: 
751.0 Meckel's diverticulum 
751.1 Atresia and stenosis of small intestine 
751.2 Atresia and stenosis of large intestine, rectum, and anal canal 
751.3 Hirschsprung's disease and other congenital functional disorders of 
colon 
751.4 Anomalies of intestinal fixation 
751.5 Other anomalies of intestine 
751.6 Anomalies of gallbladder, bile ducts, and liver 
751.7 Anomalies of pancreas 
751.8 Other specified anomalies of digestive system 
751.9 Unspecified anomaly of digestive system 
752 Congenital anomalies of genital organs 
Includes: 
752.0 Anomalies of ovaries 
752.1 Anomalies of fallopian tubes and broad ligaments 
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752.2 Doubling of uterus 
752.3 Other anomalies of uterus 
752.4 Anomalies of cervix, vagina, and external female genitalia 
752.5 Undescended and retractile testicle 
752.6 Hypospadias and epispadias and other penile anomalies 
752.7 Indeterminate sex and pseudohermaphroditism 
752.8 Other specified anomalies of genital organs 
752.9 Unspecified anomaly of genital organs 
753 Congenital anomalies of urinary system 
Includes: 
753.0 Renal agenesis and dysgenesis 
753.1 Cystic kidney disease 
753.2 Obstructive defects of renal pelvis and ureter 
753.3 Other specified anomalies of kidney 
753.4 Other specified anomalies of ureter 
753.5 Exstrophy of urinary bladder 
753.6 Atresia and stenosis of urethra and bladder neck 
753.7 Anomalies of urachus 
753.8 Other specified anomalies of bladder and urethra 
753.9 Unspecified anomaly of urinary system 
754 Certain congenital musculoskeletal deformities 
Includes: 
754.0 Of skull, face, and jaw 
754.1 Of sternocleidomastoid muscle 
754.2 Of spine 
754.3 Congenital dislocation of hip 
754.4 Congenital genu recurvatum and bowing of long bones of leg 
754.5 Varus deformities of feet 
754.6 Valgus deformities of feet 
754.7 Other deformities of feet 
754.8 Other specified nonteratogenic anomalies 
755 Other congenital anomalies of limbs 
Includes: 
755.0 Polydactyly 
755.1 Syndactyly 
755.2 Reduction deformities of upper limb 
755.3 Reduction deformities of lower limb 
755.4 Reduction deformities, unspecified limb 
755.5 Other anomalies of upper limb, including shoulder girdle 
755.6 Other anomalies of lower limb, including pelvic girdle 
755.8 Other specified anomalies of unspecified limb 
755.9 Unspecified anomaly of unspecified limb 
756 Other congenital musculoskeletal anomalies 
Includes: 
756.0 Anomalies of skull and face bones 
756.1 Anomalies of spine 
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756.2 Cervical rib 
756.3 Other anomalies of ribs and sternum 
756.4 Chondrodystrophy 
756.5 Osteodystrophies 
756.6 Anomalies of diaphragm 
756.7 Anomalies of abdominal wall 
756.8 Other specified anomalies of muscle, tendon, fascia, and connective 
tissue 
756.9 Other and unspecified anomalies of musculoskeletal system 
757 Congenital anomalies of the integument 
Includes: 
757.0 Hereditary edema of legs 
757.1 Ichthyosis congenital 
757.2 Dermatoglyphic anomalies 
757.3 Other specified anomalies of skin 
757.4 Specified anomalies of hair 
757.5 Specified anomalies of nails 
757.6 Specified anomalies of breast 
757.8 Other specified anomalies of the integument 
757.9 Unspecified anomaly of the integument 
758 Chromosomal anomalies 
Includes: 
758.0 Down syndrome 
758.1 Patau's syndrome 
758.2 Edward's syndrome 
758.3 Autosomal deletion syndromes 
758.4 Balanced autosomal translocation in normal individual 
758.5 Other conditions due to autosomal anomalies 
758.6 Gonadal dysgenesis 
758.7 Klinefelter's syndrome 
758.8 Other conditions due to chromosome anomalies 
758.9 Conditions due to anomaly of unspecified chromosome 
759 Other and unspecified congenital anomalies 
Includes: 
759.0 Anomalies of spleen 
759.1 Anomalies of adrenal gland 
759.2 Anomalies of other endocrine glands 
759.3 Situs inversus 
759.4 Conjoined twins 
759.5 Tuberous sclerosis 
759.6 Other hamartoses, NEC 
759.7 Multiple congenital anomalies, so described 
759.8 Other specified anomalies
759.9 Congenital anomaly, unspecified 
MSB Z60 Congenital dysplasia of hip 
MSB Z61 Clubfoot 
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Table A.2: Reclassification of ICD-10 codes found in the study population to ICD-9 
codes 
ICD-10 
Code 
Description Recoded 
to ICD-9 
 Q00-Q07: Congenital malformations of the nervous system  
Q00 Anencephaly and similar malformations (740) 
Q02 Microcephaly (742) 
Q03 Congenital hydrocephalus (742) 
Q04 Other congenital malformations of brain (742) 
Q05 Spina bifida (741) 
Q06 Other congenital malformations of spinal cord (742) 
Q07 Other congenital malformations of nervous system (742) 
 Q10-Q18: Congenital malformations of eye, ear, face and 
neck  
 
Q10 Congenital malformations of eyelid, lacrimal apparatus and 
orbit 
(743) 
Q11 Anophthalmos, microphthalmos and macrophthalmos (743) 
Q17 Other congenital malformations of ear (744) 
Q18 Other congenital malformations of face and neck (744) 
 Q20-Q28: Congenital malformations of the circulatory 
system  
 
Q20 Congenital malformations of cardiac chambers and connections (746) 
Q21 Congenital malformations of cardiac septa (745) 
Q22 Congenital malformations of pulmonary and tricuspid valves (747) 
Q23 Congenital malformations of aortic and mitral valves (746) 
Q24 Other congenital malformations of heart (746) 
Q25 Congenital malformations of great arteries (747) 
Q27 Other congenital malformations of peripheral vascular system (747) 
Q28 Other congenital malformations of circulatory system (747) 
 Q30-Q34: Congenital malformations of the respiratory 
system  
 
Q30 Congenital malformations of nose (748) 
 Q35-Q37: Cleft lip and cleft palate   
Q35 Cleft palate (749) 
Q37 Cleft palate with cleft lip (749) 
 Q38-Q45: Other congenital malformations of the digestive 
system  
 
Q38 Other congenital malformations of tongue, mouth and pharynx (750) 
Q39 Congenital malformations of oesophagus (750) 
Q43 Other congenital malformations of intestine (759) 
 Q50-Q56: Congenital malformations of genital organs   
Q52 Other congenital malformations of female genitalia (752) 
Q53 Undescended testicle (752) 
Q54 Hypospadias (752) 
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Q55 Other congenital malformations of male genital organs (752) 
 Q60-Q64: Congenital malformations of the urinary system   
Q61 Cystic kidney disease (753) 
Q62 Congenital obstructive defects of renal pelvis and congenital 
malformations of ureter 
(753) 
 Q65-Q79: Congenital malformations and deformations of 
the musculoskeletal system  
 
Q66 Congenital deformities of feet (754) 
Q68 Other congenital musculoskeletal deformities (754) 
Q69 Polydactyly (755) 
Q70 Syndactyly (755) 
Q74 Other congenital malformations of limb(s) (755) 
Q75 Other congenital malformations of skull and face bones (756) 
Q76 Congenital malformations of spine and bony thorax (756) 
Q78 Other osteochondrodysplasias (756) 
Q79 Congenital malformations of the musculoskeletal system, not 
elsewhere classified 
(756) 
 Q80-Q89: Other congenital malformations   
Q82 Other congenital malformations of skin (757) 
Q86 Congenital malformation syndromes due to known exogenous 
causes, not elsewhere classified 
(759) 
Q87 Other specified congenital malformation syndromes affecting 
multiple systems 
(759) 
Q89 Other congenital malformations, not elsewhere classified (759) 
 Q90-Q99: Chromosomal abnormalities, not elsewhere 
classified  
 
Q90 Down syndrome (758) 
Q91 Edwards' syndrome and Patau's syndrome (758) 
Q93 Monosomies and deletions from the autosomes, not elsewhere 
classified 
(758) 
Q96 Turner's syndrome (758) 
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APPENDIX B: REGIONAL DIFFERENCES IN THE MEAN NUMBER OF 
CASES OF CONGENITAL ANOMALIES BY REGIONAL HEALTH 
AUTHORITY 
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Figure B.1: Regional differences in the mean number of cases of children with CAs 
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Figure B.2: Regional differences in the mean number of cases of children with multiple 
CAs 
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Figure B.3: Regional differences in the mean number of cases of children with neural 
tube defects (ICD-9 740 and 741) 
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Figure B.4: Regional differences in the mean number of cases of children with other 
congenital anomalies of nervous system (ICD-9 742) 
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Figure B.5: Regional differences in the mean number of cases of children with 
congenital anomalies of eye (ICD-9 743) 
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Figure B.6: Regional differences in the mean number of cases of children with 
congenital anomalies of ear, face, and neck (ICD-9 744) 
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Figure B.7: Regional differences in the mean number of cases of children with bulbus 
cordis anomalies and anomalies of cardiac septal closure (ICD-9 745) 
 
Northern
Saskatche
wan
Prairie
North RHA
Prince
Albert
Parkland
RHA
Kelsey
Trail RHA
Heartland
RHA
Saskatoon
RHA
Sunrise
RHA
Regina
Qu'Appelle
RHA
Cypress
RHA
Five Hills
RHA
Sun
Country
RHA
RHA of Residence as at Dec 31 of Baby's 1st Year of Follow-up
0.05
0.04
0.03
0.02
0.01
0.00
95
%
 C
I IC
D9
 7
46
Regional Differences in ICD9 746
 
Figure B.8: Regional differences in the mean number of cases of children with other 
congenital anomalies of heart (ICD-9 746) 
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Figure B.9: Regional differences in the mean number of cases of children with other 
congenital anomalies of circulatory system (ICD-9 747) 
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Figure B.10: Regional differences in the mean number of cases of children with 
congenital anomalies of respiratory system (ICD-9 748) 
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Figure B.11: Regional differences in the mean number of cases of children with cleft 
palate and cleft lip (ICD-9 749) 
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Figure B.12: Regional differences in the mean number of cases of children with other 
congenital anomalies of upper alimentary tract (ICD-9 750) 
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Figure B.13: Regional differences in the mean number of cases of children with other 
congenital anomalies of digestive system (ICD-9 751) 
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Figure B.14: Regional differences in the mean number of cases of children with 
congenital anomalies of genital organs (ICD-9 752) 
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Figure B.15: Regional differences in the mean number of cases of children with 
congenital anomalies of urinary system (ICD-9 753) 
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Figure B.16: Regional differences in the mean number of cases of children with certain 
congenital musculoskeletal deformities (ICD-9 754) 
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Figure B.17: Regional differences in the mean number of cases of children with other 
congenital anomalies of limbs (ICD-9 755) 
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Figure B.18: Regional differences in the mean number of cases of children with other 
congenital musculoskeletal anomalies (ICD-9 756) 
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Figure B.19: Regional differences in the mean number of cases of children with 
congenital anomalies of the integument (ICD-9 757) 
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Figure B.20: Regional differences in the mean number of cases of children with 
chromosomal anomalies (ICD-9 758) 
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Figure B.21: Regional differences in the mean number of cases of children with other 
and unspecified congenital anomalies (ICD-9 759) 
Northern
Saskatche
wan
Prairie
North RHA
Prince
Albert
Parkland
RHA
Kelsey
Trail RHA
Heartland
RHA
Saskatoon
RHA
Sunrise
RHA
Regina
Qu'Appelle
RHA
Cypress
RHA
Five Hills
RHA
Sun
Country
RHA
RHA of Residence as at Dec 31 of Baby's 1st Year of Follow-up
0.06
0.05
0.04
0.03
0.02
0.01
0.00
95
%
 C
I I
CD
9 6
0
Regional Differences in ICD9 60
 
Figure B.22: Regional differences in the mean number of cases of children with 
congenital dysplasia of hip (MSB Z60) 
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Figure B.23: Regional differences in the mean number of cases of children with 
clubfoot (MSB Z61) 
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